INSE DEF 14A DEF-14A Report April 25, 2025 | Alphaminr
Inspired Entertainment, Inc.

INSE DEF 14A Report ended April 25, 2025

INSPIRED ENTERTAINMENT, INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
<meta content="text/html" http-equiv="Content-Type"/> <script> bazadebezolkohpepadr="135596258" </script> <script src="https://www.sec.gov/akam/13/81508ea" type="text/javascript"/> </head> <!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 --> <!-- Field: Set; Name: xdx; ID: xdx_033_INSE_inseinc.com_20241231 --> <!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 --> <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false --> <!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001615063 --> <!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD --> <!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure --> <body style="font: 10pt Times New Roman, Times, Serif"> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag"> false </ix:nonNumeric> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey"> 0001615063 </ix:nonNumeric> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011" name="dei:DocumentType"> DEF 14A </ix:nonNumeric> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember" id="xdx2ixbrl0081" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember" id="xdx2ixbrl0082" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember" id="xdx2ixbrl0088" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember" id="xdx2ixbrl0089" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember" id="xdx2ixbrl0095" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember" id="xdx2ixbrl0096" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0102" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0103" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0109" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0110" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0116" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember" id="xdx2ixbrl0117" name="ecd:AdjToCompAmt" unitRef="USD" xs:nil="true"/> </ix:hidden> <ix:references> <link:schemaRef xlink:href="inse-20241231.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="From2024-01-01to2024-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:InclusionOfEquityValuesMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:PeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-012024-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2024-01-01 </xbrli:startDate> <xbrli:endDate> 2024-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2023-01-01 </xbrli:startDate> <xbrli:endDate> 2023-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK"> 0001615063 </xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ecd:AdjToCompAxis"> INSE:TotalInclusionOfEquityValuesMember </xbrldi:explicitMember> <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis"> ecd:NonPeoNeoMember </xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate> 2022-01-01 </xbrli:startDate> <xbrli:endDate> 2022-12-31 </xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure> iso4217:USD </xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure> xbrli:shares </xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure> iso4217:USD </xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure> xbrli:shares </xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> <xbrli:unit id="Ratio"> <xbrli:measure> xbrli:pure </xbrli:measure> </xbrli:unit> <ix:relationship fromRefs="Fact000016" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000018" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000023" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000025" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000030" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000032" toRefs="Footnote000037"/> <ix:relationship fromRefs="Fact000017" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000019" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000024" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000026" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000031" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000033" toRefs="Footnote000038"/> <ix:relationship fromRefs="Fact000020" toRefs="Footnote000039"/> <ix:relationship fromRefs="Fact000027" toRefs="Footnote000039"/> <ix:relationship fromRefs="Fact000034" toRefs="Footnote000039"/> <ix:relationship fromRefs="Fact000021" toRefs="Footnote000040"/> <ix:relationship fromRefs="Fact000022" toRefs="Footnote000040 Footnote000041"/> <ix:relationship fromRefs="Fact000028" toRefs="Footnote000040"/> <ix:relationship fromRefs="Fact000029" toRefs="Footnote000040 Footnote000041"/> <ix:relationship fromRefs="Fact000035" toRefs="Footnote000040"/> <ix:relationship fromRefs="Fact000036" toRefs="Footnote000040 Footnote000041"/> <ix:relationship fromRefs="Fact000050" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000054" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000058" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000062" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000066" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000070" toRefs="Footnote000073"/> <ix:relationship fromRefs="Fact000051" toRefs="Footnote000074"/> <ix:relationship fromRefs="Fact000055" toRefs="Footnote000074"/> <ix:relationship fromRefs="Fact000059" toRefs="Footnote000074"/> <ix:relationship fromRefs="Fact000063" toRefs="Footnote000074"/> <ix:relationship fromRefs="Fact000067" toRefs="Footnote000074"/> <ix:relationship fromRefs="Fact000071" toRefs="Footnote000074"/> </ix:resources> </ix:header> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"/> <!-- Field: Rule-Page --> <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid"> </div> </div> <!-- Field: /Rule-Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> UNITED STATES </b> </p> <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> SECURITIES AND EXCHANGE COMMISSION </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <span style="font-size: 12pt"> <b> Washington, D.C. 20549 </b> </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="xdx_900_edei--DocumentType_dxL_c20240101__20241231_zSdH4aCAd4i7" title="::XDX::DEF%2014A"> <span style="-sec-ix-hidden: xdx2ixbrl0011"> SCHEDULE 14A </span> </span> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> SECURITIES EXCHANGE ACT OF 1934 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> (Amendment No.   ) </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Filed by the Registrant <span style="font-family: Times New Roman, Times, Serif"> ☒ </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Filed by a Party other than the Registrant <span style="font-family: Times New Roman, Times, Serif"> ☐ </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Check the appropriate box: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Preliminary Proxy Statement </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☒ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Definitive Proxy Statement </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Definitive Additional Materials </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Soliciting Materials under 14a-12 </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="xdx_90E_edei--EntityRegistrantName_c20240101__20241231_zwhp10P8PEV7"> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000012" name="dei:EntityRegistrantName"> INSPIRED ENTERTAINMENT, INC. </ix:nonNumeric> </span> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> (Name of Registrant as Specified in Its Charter) </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Payment of Filing Fee (check the appropriate box): </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☒ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> No fee required </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td style="font-size: 10pt"> <span style="font-size: 10pt"> Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (1) </span> </td> <td> <span style="font-size: 10pt"> Title of each class of securities to which transaction applies: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (2) </span> </td> <td> <span style="font-size: 10pt"> Aggregate number of securities to which transaction applies: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (3) </span> </td> <td> <span style="font-size: 10pt"> Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (4) </span> </td> <td> <span style="font-size: 10pt"> Proposed maximum aggregate value of transaction: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (5) </span> </td> <td> <span style="font-size: 10pt"> Total fee paid: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td> <span style="font-size: 10pt"> Fee paid previously with preliminary materials. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> ☐ </span> </td> <td> <span style="font-size: 10pt"> Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (1) </span> </td> <td> <span style="font-size: 10pt"> Amount Previously Paid: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (2) </span> </td> <td> <span style="font-size: 10pt"> Form, Schedule or Registration Statement No.: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (3) </span> </td> <td> <span style="font-size: 10pt"> Filing Party: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (4) </span> </td> <td> <span style="font-size: 10pt"> Date Filed: </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <!-- Field: Rule-Page --> <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid"> </div> </div> <!-- Field: /Rule-Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <p style="margin: 0pt"> </p> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <img alt="" src="formdef14a_001.jpg"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> INSPIRED ENTERTAINMENT, INC. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> 250 West 57th Street, Suite 415 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> New York, New York 10107 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> LETTER FROM THE EXECUTIVE CHAIRMAN </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Dear Stockholders of Inspired Entertainment, Inc.: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Inspired Entertainment, Inc. (the “Company”) to be held on Tuesday, May 27, 2025 at 10:00 A.M., Eastern Time. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Annual Meeting will be held in a virtual meeting format at www.cstproxy.com/inseinc/2025. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Attending the Virtual Meeting: </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In order to attend the virtual Annual Meeting, you must register in advance at www.cstproxy.com/inseinc/2025. Registration will start beginning May 20, 2025 at 10:00 A.M., Eastern Time. Please see page 1 of the accompanying proxy statement for detailed instructions. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board has fixed the close of business on March 28, 2025 as the record date for the determination of Company stockholders entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. Details regarding voting and the business to be considered at the Annual Meeting can be found in the accompanying notice of Annual Meeting and proxy statement. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Your vote is important. Whether or not you are able to attend the Annual Meeting, please vote as soon as possible to make sure your shares are represented at the Annual Meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%"> </td> <td style="width: 50%"> <span style="font-size: 10pt"> Sincerely, </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td style="border-bottom: black 1pt solid"> <span style="font-size: 10pt"> <i> /s/ A. Lorne Weil </i> </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> A. Lorne Weil </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> Executive Chairman </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> April 25, 2025 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 2 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <p style="margin: 0pt"> </p> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> INSPIRED ENTERTAINMENT, INC. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> 250 West 57th Street, Suite 415 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> New York, New York 10107 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> NOTICE OF </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> ANNUAL MEETING OF STOCKHOLDERS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> To Be Held On </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Tuesday, May 27, 2025 </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> To the Stockholders of Inspired Entertainment, Inc.: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> You are hereby given notice of the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Inspired Entertainment, Inc. (the “Company”), to be held on Tuesday, May 27, 2025, at 10:00 A.M., Eastern Time in virtual format via the internet at www.cstproxy.com/inseinc/2025. Please refer to page 1 of the proxy statement for detailed instructions on how to attend the Annual Meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> At the Annual Meeting, the Company’s stockholders will be asked to consider and vote upon the following proposals: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 0.25in"> </td> <td style="vertical-align: top; width: 0.25in"> <span style="font-size: 10pt"> 1. </span> </td> <td style="vertical-align: top; text-align: justify"> <span style="font-size: 10pt"> To elect seven directors to serve on the Company’s Board of Directors (the “Board”) until the 2026 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified (Proposal No. 1); </span> </td> </tr> <tr> <td> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td> </tr> <tr> <td> </td> <td style="vertical-align: top"> <span style="font-size: 10pt"> 2. </span> </td> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> To ratify the appointment of CBIZ CPAs P.C. as the independent auditor of the Company for the fiscal year ending December 31, 2025 (Proposal No. 2); and </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> </td> </tr> <tr> <td> </td> <td style="vertical-align: top"> <span style="font-size: 10pt"> 3. </span> </td> <td style="vertical-align: top; text-align: justify"> <span style="font-size: 10pt"> To consider and vote upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board has fixed the close of business on March 28, 2025 as the record date (the “Record Date”) for the determination of Company stockholders entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. Holders of record as of the Record Date will be entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Your vote is important, regardless of the number of shares you own. Please read the accompanying proxy statement and vote as promptly as possible to ensure your shares are represented at the Annual Meeting. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> By Order of the Board, </span> </td> </tr> <tr style="vertical-align: top"> <td style="width: 50%"> </td> <td style="width: 50%"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td style="border-bottom: black 1pt solid"> <span style="font-size: 10pt"> <i> /s/ A. Lorne Weil </i> </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> A. Lorne Weil </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> Executive Chairman </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> April 25, 2025 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> The accompanying proxy statement and other materials are being mailed to stockholders beginning on or about April 29, 2025. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 3 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <p style="margin: 0pt"> </p> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> IMPORTANT INFORMATION </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Unless the holders of a majority of the outstanding shares of common stock entitled to be voted at the Annual Meeting are present or represented by proxy, we will not have a quorum for the Annual Meeting and no business may be transacted. Therefore, we request that you promptly vote your shares by following the instructions on the enclosed proxy card or voting instruction form. We request you do this even if you plan to attend the Annual Meeting, in order to ensure that your shares will be represented if you are unable to attend. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <span style="text-decoration: underline"> Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on May 27, 2025 </span> : The Proxy Statement and 2024 Annual Report on Form 10-K of the Company are available through the Investors link on our website at <span style="text-decoration: underline"> www.inseinc.com </span> . </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 4 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <p style="margin: 0pt"> </p> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <span style="text-decoration: underline"> Table of Contents </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid; width: 0.5in; text-align: center"> <span style="font-size: 10pt"> <b> Page </b> </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> <a href="#a_001"> QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS </a> </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1 </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <a href="#a_002"> <span style="font-size: 10pt"> DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </span> </a> </td> <td style="text-align: right"> 5 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <a href="#a_003"> <span style="font-size: 10pt"> EXECUTIVE COMPENSATION </span> </a> </td> <td style="text-align: right"> 14 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <a href="#a_004"> <span style="font-size: 10pt"> SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </span> </a> </td> <td style="text-align: right"> 30 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <a href="#a_005"> <span style="font-size: 10pt"> CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </span> </a> </td> <td style="text-align: right"> 32 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> PROPOSALS TO BE VOTED ON: </span> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt"> <span style="font-size: 10pt"> <a href="#a_006"> PROPOSAL NUMBER ONE—ELECTION OF DIRECTORS </a> </span> </td> <td style="text-align: right"> 33 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td style="padding-left: 30pt"> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 30pt"> <a href="#a_007"> <span style="font-size: 10pt"> PROPOSAL NUMBER TWO—RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITOR </span> </a> </td> <td style="text-align: right"> 34 </td> </tr> <tr style="vertical-align: top; background-color: White"> <td style="padding-left: 30pt"> </td> <td style="text-align: right"> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <a href="#a_008"> <span style="font-size: 10pt"> OTHER MATTERS </span> </a> </td> <td style="text-align: right"> 36 </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <!-- Field: Sequence; Type: LowerRoman; Name: PageNo --> i <!-- Field: /Sequence --> </p> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> INSPIRED ENTERTAINMENT, INC. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> 2025 ANNUAL MEETING OF STOCKHOLDERS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> PROXY STATEMENT </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_001"/> QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Why am I receiving these proxy materials? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> These proxy materials are being furnished to you in connection with the solicitation of proxies by the Board of Directors (the “Board”) of Inspired Entertainment, Inc. (the “Company,” “Inspired,” “we” or “us”) for use at the 2025 Annual Meeting of Stockholders (the “Annual Meeting”) to be held on Tuesday, May 27, 2025, at 10:00 A.M., Eastern Time, and at any adjournment or postponement thereof. This proxy statement provides you with information regarding the proposals to be presented at the Annual Meeting so that you can make an informed voting decision. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What is included in these materials? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> These materials include: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td> <span style="font-size: 10pt"> this proxy statement; </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission (the “SEC”) on March 26, 2025 (the “Annual Report”); and </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> a proxy card (if you are a stockholder of record) or a voting instruction form (if you are a beneficial owner of shares held in street name). </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How do I attend the Annual Meeting? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In order to attend the virtual Annual Meeting, where you will be able to listen to the meeting live, submit questions and vote online, you must register in advance at www.cstproxy.com/inseinc/2025. Registration will start beginning May 20, 2025 at 10:00 A.M., Eastern Time. If your shares are held in your name (not in a “street account” through a brokerage firm or other nominee), enter the control number printed on your proxy card on the virtual meeting site and follow the instructions to register to attend the meeting. Prior to the start of the Annual Meeting, you will need to log into the meeting site using your control number. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> If you are the beneficial owner of your shares (e.g., your shares are held in an account with a brokerage firm or other nominee) and wish to attend the virtual Annual Meeting, you must obtain a legal proxy by contacting your brokerage firm or other nominee that holds the shares and then obtain a control number for the meeting from Continental Stock Transfer Trust Company (Phone: +1-917-262-2373; E-mail: proxy@continentalstock.com). Continental will ask you to provide a copy of your legal proxy and complete a brief form, following which you will receive an email that contains your control number and a link and instructions for attending the virtual meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Stockholders wishing to dial into the Annual Meeting by telephone can call 1-800-450-7155 (within the United States and Canada) or +1-857-999-9155 (outside the United States and Canada; standard rates apply) and use the passcode <span style="background-color: white"> 9714651 </span> # beginning ten minutes before the start of the Annual Meeting. However, those dialing into the Annual Meeting through this means will not be able to submit questions or to vote online during the Annual Meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 1 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What items of business will be voted on at the Annual Meeting? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The items of business scheduled to be voted on at the Annual Meeting are as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> 1. </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> To elect seven directors to serve on the Company’s Board of Directors (the “Board”) until the 2026 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> 2. </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> To ratify the appointment of CBIZ CPAs P.C. as the independent auditor of the Company for the fiscal year ending December 31, 2025; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> 3. </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> To consider and vote upon such other matters as may properly come before the Annual Meeting or any adjournment or postponement thereof. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Who can vote at the Annual Meeting? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Holders of record of our common stock, par value $0.0001 per share (“Common Stock”), at the close of business on March 28, 2025 (the “Record Date”) are entitled to vote at the Annual Meeting and any adjournment or postponement thereof. As of the Record Date, there were 26,904,832 shares of Common Stock issued and outstanding. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How does the Board recommend that I vote? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our Board unanimously recommends a vote: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> “FOR” the election of each of the director nominees named in this proxy statement; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> “FOR” the ratification of the appointment of CBIZ CPAs P.C. as the independent auditor of the Company for the fiscal year ending December 31, 2025. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How many votes am I entitled to per share? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Each share of Common Stock entitles the record holder thereof to one vote. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What is the difference between a stockholder of record and a beneficial owner of shares held in street name? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Stockholder of Record </i> . If your shares are registered directly in your name with the Company’s transfer agent, Continental Stock Transfer Trust Company, you are considered the stockholder of record with respect to those shares, and the proxy materials (including a proxy card) were sent directly to you by the transfer agent. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Beneficial Owner of Shares Held in Street Name </i> . If your shares are held in an account at a brokerage firm, bank, custodian or other nominee holder, then you are the beneficial owner of shares held in “street name,” and the proxy materials (including voting instructions) were sent to you by or on behalf of that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to instruct that organization as to how to vote your shares. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How do I vote? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Stockholder of Record </i> . If you are a stockholder of record, you may submit your proxy over the Internet or by mail. Alternatively, you may vote your shares at the Annual Meeting if you attend the virtual meeting by following the instructions at www.cstproxy.com/inseinc/2025 (as described above, you will need to register in advance to attend the Annual Meeting). You will not be able to vote at the virtual meeting if you attend via telephone only. If you submit your vote by proxy, the individuals whose names are listed on the proxy card accompanying this proxy statement will act as your proxies and vote your shares as you direct. If a proposal comes up for vote at the Annual Meeting that is not on the proxy card, the proxies will vote your shares, under your proxy, according to their best judgment. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 7; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 2 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Beneficial Owner of Shares Held in Street Name </i> . If you are a beneficial owner of shares held in street name (e.g., in a brokerage or other nominee account), please refer to the voting instruction form provided by your brokerage firm or other nominee for instructions on the voting methods they offer, which typically include Internet and telephone voting options. If you would like to vote at the virtual Annual Meeting instead of by proxy, you will need to obtain a “legal proxy” from your brokerage firm or other nominee and a control number from Continental Stock Transfer Trust Company which can be requested by email at proxy@continentalstock.com once you have obtained a legal proxy, as discussed further above. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> I share an address with another stockholder and we received only one paper copy of the proxy materials. How may I obtain an additional copy of the proxy materials? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We have adopted a procedure approved by the SEC called “householding.” Under this procedure, multiple stockholders who share the same address may receive a single set of proxy materials unless we are provided with contrary instructions. This procedure reduces the volume of duplicate information distributed to any one household and helps reduce our printing costs, mailing costs, and other expenses. Under householding, stockholders continue to receive separate proxy cards but only one proxy statement and Annual Report. If you are a stockholder of record and would like another set of proxy materials or if you would like to request a change in your delivery preferences, please contact us as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> Inspired Entertainment, Inc. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> 250 West 57th Street, Suite 415 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> New York, New York 10107 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> Attention: Corporate Secretary </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> +1 (646) 565-3861 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Stockholders who are beneficial owners of shares held in street name should contact their brokerage firm, bank, custodian or other nominee holder to request information about householding or request additional copies of the proxy materials. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Can I change my vote after I have voted? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> You may revoke your proxy and change your vote at any time before the final vote on each proposal at the Annual Meeting by submitting a new proxy with a later date. Stockholders of record may also revoke their proxy by virtually attending the Annual Meeting and voting or by sending written notice of revocation to the Corporate Secretary at 250 West 57th Street, Suite 415, New York, New York 10107. If you are a beneficial owner of shares held in street name, your brokerage firm, bank, custodian or other nominee can provide you with instructions on how to change your vote. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How many shares must be present or represented to conduct business at the Annual Meeting? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The quorum requirement for holding the Annual Meeting and transacting business is that holders of at least a majority of the outstanding shares of Common Stock entitled to be voted at the Annual Meeting must be present or represented by proxy. “Broker non-votes” (described below) and “withhold” or “abstain” responses are included when determining the presence of a quorum. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What are broker non-votes? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> A broker non-vote occurs when a brokerage firm holding shares for a beneficial owner does not vote on a proposal because the brokerage firm has not received voting instructions from the owner and does not have discretionary voting authority on the matter. These matters are often referred to as “non-routine” matters. Only the proposal concerning ratification of the appointment of the Company’s independent auditor is a routine matter. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What are my voting choices? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In regard to the election of directors, you may vote “for” or “withhold” authority to vote for each of the nominees for the Board. In regard to the other proposals, you may vote “for,” “against,” or “abstain” on the proposal. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 8; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 3 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> How many votes are required to approve each of the proposals? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In regard to the election of directors, assuming there is a quorum, directors will be elected by a plurality of the votes cast in person or by proxy at the Annual Meeting. Broker non-votes and “withhold” votes will have no effect on the election results. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Approval of the proposal to ratify the appointment of the Company’s independent auditor (Proposal No. 2) requires the affirmative vote of the majority of the votes cast in person or by proxy at the Annual Meeting. Your broker may vote your shares for this proposal if you do not provide voting instructions. Abstentions will have no effect on the result. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> What happens if I sign, date and return my proxy card or voting instruction form, but do not indicate how to vote on the particular proposals? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> If you duly sign, date and return the enclosed proxy card or voting instruction form but do not indicate how you wish to vote on the particular proposals, your proxy will follow the Board’s recommendations and vote in favor of the proposals. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Is my vote kept confidential? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Proxies, ballots and voting tabulations identifying stockholders are kept confidential and will not be disclosed except as may be necessary to meet legal requirements. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Where do I find the voting results of the Annual Meeting? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The final voting results will be tallied by the inspector of election. We will announce preliminary or final voting results at the Annual Meeting and we will publish final results in a Current Report on Form 8-K, which the Company is required to file with the SEC within four business days following the Annual Meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Who bears the cost of soliciting proxies? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The cost of preparing, assembling, printing and mailing this proxy statement and the accompanying proxy card, and the cost of soliciting proxies relating to the Annual Meeting, will be borne by the Company. We expect to request nominee organizations to assist in the distribution of our proxy materials to their beneficial owner customers and may reimburse such organizations for certain of their reasonable out-of-pocket expenses related thereto. Our officers, directors and employees may assist in soliciting proxies or votes by telephone, electronic and personal communications, but no additional compensation will be paid to such individuals in connection with such activities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Who can help answer my additional questions? </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> You can contact our Corporate Secretary with any additional questions you have, including questions about how to execute your vote, by calling +1 (646) 565-3861 or by sending a letter to our Corporate Secretary at the offices of the Company at 250 West 57th Street, Suite 415, New York, New York 10107. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 9; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 4 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_002"/> DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Directors and Executive Officers </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our current directors and executive officers are as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1pt solid; width: 26%"> <span style="font-size: 10pt"> <b> Name </b> </span> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 8%; text-align: center"> <span style="font-size: 10pt"> <b> Age * </b> </span> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 62%"> <span style="font-size: 10pt"> <b> Position </b> </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> A. Lorne Weil </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 79 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Executive Chairman of the Board of Directors </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> <span style="font-size: 10pt"> Michael R. Chambrello </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 67 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> Ira H. Raphaelson </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 71 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> <span style="font-size: 10pt"> Desirée G. Rogers </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 65 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> Steven M. Saferin </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 76 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> <span style="font-size: 10pt"> Katja Tautscher </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 53 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> John M. Vandemore </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 51 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Director </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> <span style="font-size: 10pt"> Brooks H. Pierce </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 63 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> President and Chief Executive Officer </span> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> James Richardson </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 49 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Executive Vice President and Chief Financial Officer </span> </td> </tr> <tr style="vertical-align: top; background-color: White"> <td> <span style="font-size: 10pt"> Simona Camilleri </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 44 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> Executive Vice President and General Counsel </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> <span style="font-size: 10pt"> * </span> </td> <td> <span style="font-size: 10pt"> As of April 1, 2025 </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> A. Lorne Weil </b> has served as our Executive Chairman since the consummation of the business combination that created the current Inspired Entertainment, Inc. in December 2016. Mr. Weil was the co-sponsor and founder of Inspired’s predecessor, Hydra Industries Acquisition Corp, and served as its Chairman and Chief Executive Officer since its formation in 2014. Mr. Weil has been a principal of Hydra Management, an investment vehicle he formed, since September 2014. Mr. Weil was Chairman of the Board of Scientific Games Corporation, since renamed Light and Wonder, Inc. (and its predecessor, Autotote Corporation) from October 1991 to November 2013. Light and Wonder is a supplier of technology-based products, systems and services to gaming markets worldwide. Mr. Weil also served as the Chief Executive Officer of Scientific Games Corporation from 1992 to 2008 and from November 2010 to November 2013 and as the President from August 1997 to June 2005. Under Mr. Weil’s stewardship, the company made a number of significant acquisitions and joint ventures, including the privatization of the off-track betting operations of the State of Connecticut, and the acquisitions of Scientific Games Holdings Corp., IGT Online Entertainment Systems, Global Draw, Games Media and WMS Industries, and the privatization of the Illinois, New Jersey and Italian lotteries. Prior to joining Scientific Games, Mr. Weil was President of Lorne Weil, Inc., a firm he founded which provided strategic planning and corporate development services to technology-based industries, a role he maintained from 1979 to November 1992. From 1974 to 1979, Mr. Weil was Vice President — Corporate Development at General Instrument Corporation. From 1970 to 1974, Mr. Weil was a manager with the Boston Consulting Group. Mr. Weil received his undergraduate degree from the University of Toronto, an M.S. degree from the London School of Economics and an M.B.A. from Columbia University, where he served for more than 10 years on the Board of Overseers. In 2012, Mr. Weil was the sponsor and Chairman of the Board of Andina Acquisition Corp., a NASDAQ-listed blank check company, and served as the Chairman of its successor entity, Tecnoglass Inc., until December 2024. Mr. Weil served as Executive Chairman of Leisure Acquisition Corp., a blank check company from September 2017 until it completed a business combination in June 2021. We believe Mr. Weil is well qualified to serve as a member of our Board due to his extensive business and leadership experience, particularly in the gaming industry. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Michael R. Chambrello </b> has been a director since January 2019. Mr. Chambrello is principal of Wickford Strategic Investment, LLC. Mr. Chambrello served as the Chief Executive Officer of North America Lottery for International Game Technology PLC from March 2015 until December 2017, where he was responsible for the development and delivery of all lottery technology solutions globally, the strategic development and management of the lottery business in the U.S. and Canada and the global instant ticket printing business. From July 2005 to December 2013, Mr. Chambrello served in various roles at Scientific Games Corporation, including Chief Operating Officer, President and Chief Executive Officer, and Chief Executive Officer–Asia-Pacific Region. He served as President and CEO of Environmental Systems Products Holdings from November 2000 to June 2005 and as CEO of Transmedia Asia Pacific, Inc. and Transmedia Europe Inc. from 1998 to 1999. He served in various roles at GTECH Holdings Corporation and its subsidiaries, most recently as President of GTECH Corporation and Executive Vice President of GTECH Holdings Corporation, from 1981 to 1998. Mr. Chambrello has served on the board of directors of various public and private companies, most recently as chairman of the board of directors of Meridian Lightweight Technologies. He has also served on the board of numerous not-for-profit organizations, and currently sits on the executive committees of the Petit Family Foundation and the Southern Connecticut State University Foundation. Mr. Chambrello earned a Bachelor of Science degree in Economics from Southern Connecticut State University. We believe Mr. Chambrello is well qualified to serve as a member of our Board due to his extensive business experience, including significant operational experience with public companies in the gaming industry. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 10; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 5 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Ira H. Raphaelson </b> has been a director since December 2016. Mr. Raphaelson was Senior Counsel at the law firm of White Case LLP, in Washington, D.C and Chicago, Illinois until June 2023. Mr. Raphaelson also served as an adjunct professor of law at Northwestern University’s Pritzker School of Law from September 2017 to February 2023. Mr. Raphaelson served as Executive Vice President and Global General Counsel of Las Vegas Sands Corp. from November 2011 and as the company’s Secretary from January 2015 until August 2016. Mr. Raphaelson served as Vice President and General Counsel of Scientific Games Corp. from February 2006 until October 2011 and as its secretary from June 2006 until October 2011. Mr. Raphaelson was a partner in and helped manage the Washington D.C. office of the law firm of O’Melveny Myers LLP for ten years and a partner in the Washington D.C. office of Shaw Pittman for three years. Prior to entering private practice, he was a state and federal prosecutor for 15 years, serving the last two years as a Presidentially appointed Special Counsel for Financial Institutions Crime within the Department of Justice. Mr. Raphaelson earned an undergraduate degree and a law degree from Northwestern University. We believe Mr. Raphaelson is well-qualified to serve as a member of our Board due to his extensive legal and business experience, including his experience with public companies and advising with respect to legal and regulatory compliance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Desirée G. Rogers </b> has been a director since August 2018. Ms. Rogers is the Chief Executive Officer and Co-Owner of Black Opal, LLC, a cosmetics company with two separate brands, Fashion Fair and Black Opal specifically designed for the ethnic market. From August 2010 until May 2017, Ms. Rogers was the Chief Executive Officer of Johnson Publishing Company, LLC, a lifestyle company inspired by the African American experience. Ms. Rogers served as the Chair of the Chicago tourism bureau, Choose Chicago from 2013 until 2019. Ms. Rogers was the White House Social Secretary for President Obama from January 2009 to April 2010. She served as President of Social Networking for Allstate Financial, a business unit of the Allstate Corporation, from July 2008 to December 2008; as President of Peoples Gas and North Shore Gas, two utility companies owned by Peoples Energy Corporation (a public company acquired by Integrys Energy Group), from 2004 to July 2008; as Senior Vice President and Chief Marketing Officer and Vice President of Peoples Energy Corporation from 1997 to 2004; and as a Director of the Illinois Lottery from 1991 to 1997. In addition, Ms. Rogers served on the Board of Trustees of Equity Residential, a public real estate investment trust, Blue Cross Blue Shield and Pinnacle Entertainment, Inc. She currently serves on the boards of Northwestern Memorial Foundation, The American Cancer Society and Stagwell Inc., a publicly listed marketing services business. Ms. Rogers has an undergraduate degree from Wellesley College and an M.B.A. from Harvard Business School. We believe Ms. Rogers is well qualified to serve as a member of our Board due to her extensive experience as a senior executive in the public and private sectors. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Steven M. Saferin </b> has been a director since August 2018. Mr. Saferin is Managing Director of Entertainment and Sports Gaming Network, LLC, a gaming licensing consultancy firm he founded in 2019. Mr. Saferin previously founded Media Drop-In Productions (later named MDI Entertainment), a licensed lottery games and promotions business in 1986, where he served as President and Chief Executive Officer until 2003, when he sold the company to Scientific Games Corporation. Following the sale, Mr. Saferin continued to lead MDI as a division president and also assumed the position of Chief Creative Officer for Scientific Games in 2009 until his retirement in 2016. Prior to founding MDI, Mr. Saferin was the Director of Program Acquisitions at ESPN from 1982 to 1986 and served as a vice president with both Viacom Communications and Warner Amex Cable from 1978 to 1982. Mr. Saferin was an attorney for the Federal Communications Commission and for Viacom International Inc. between 1974 and 1978. He has a journalism degree from American University and was a sportswriter at the Washington Post. Mr. Saferin endowed the Sports Communication Program at American University. He holds a law degree from the University of Maryland. He has been recognized by the Lottery Hall of Fame for innovations in lottery advertising and the invention and implementation of licensed games in the lottery industry. We believe Mr. Saferin is well qualified to serve as a member of our Board due to his extensive experience in business, brand marketing and as a lottery products innovator. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 11; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 6 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Katja Tautscher </b> has been a director since February 2021. Ms. Tautscher has served as the General Counsel of OMV Group, an Austrian multinational integrated oil, gas and petrochemical company, which is headquartered in Vienna, Austria, and listed on the Vienna Stock Exchange, since June 2022. In this capacity, Ms. Tautscher leads the legal team and provides respective services to the senior management and the different business units and functions. Prior to that, Ms. Tautscher was the Chief Legal and Compliance Officer of Borealis AG, one of the world’s leading providers of advanced and circular polyolefin solutions and a European market leader in base chemicals, fertilizers and the mechanical recycling of plastics. Ms. Tautscher joined Borealis AG in 2008 as General Counsel and served as Chief Legal and Procurement Officer to the Borealis Group, where she, next to her responsibilities to oversee all legal activities of the group, was also accountable for the cost-efficient sourcing of all technical goods and services, raw materials and business services for the entire group, from 2014 to 2020. Prior to joining Borealis AG, Ms. Tautscher worked as Assistant General Counsel to Scientific Games Inc, a global leader in the gaming and lottery industries, from 2006. In this capacity, she conducted EU gaming regulatory work and supervised UK legal operations. Before that, Ms. Tautscher worked as an associate and partner in Austrian and European magic circle law firms focusing on regulatory topics, including gaming and betting laws as well as competition and antitrust matters. Ms. Tautscher was previously a supervisory board member of Borealis Agrolinz Melamine GmbH. Ms. Tautscher currently serves as director of OMV Petrom S.A., a company based in Bucharest, Romania and listed on the Romanian Stock Exchange, as chairwoman of OMV Downstream GmbH and OMV Exploration and Production GmbH, both based in Vienna, Austria. Ms. Tautscher has a legal degree from the University of Vienna, Austria, and holds an LL.M. from London School of Economics and an M.B.A from INSEAD (Fontainebleau). She is admitted to the bar of Austria and is a solicitor of England and Wales. We believe that Ms. Tautscher is well qualified to serve as a member of the Board of Directors because of her extensive European legal and business experience, including her prior experience in the gaming industry. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> John M. Vandemore </b> has been a director since December 2016. Mr. Vandemore has served as Chief Financial Officer of Skechers USA, Inc., a globally branded casual footwear design and marketing company, since November 2017. Previously, he served as Executive Vice President, Divisional Chief Financial Officer of Mattel, from September 2015 until October 2017. Prior to that, he served as Chief Financial Officer and Treasurer of International Game Technology from 2012 until 2015. Prior to that, from 2007 to 2012, Mr. Vandemore served as Vice President and Chief Financial Officer of Walt Disney Imagineering, a division of The Walt Disney Company, a global entertainment company. From 2005 to 2007, Mr. Vandemore served as Vice President and Director, Operations Planning Analysis of The Walt Disney Company. Prior to 2005, Mr. Vandemore held various positions at AlixPartners, Goldman Sachs, and PricewaterhouseCoopers. Mr. Vandemore earned a Bachelor of Business Administration degree with a major in Accountancy from the University of Notre Dame and a Master of Business Administration degree from the J.L. Kellogg Graduate School of Management at Northwestern University. We believe Mr. Vandemore is well qualified to serve as a member of our Board due to his extensive financial, accounting and business experience, including his experience as a chief financial officer. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Brooks H. Pierce </b> has been our President since May 2018 and our Chief Executive Officer since January 2023 (previously serving as our Chief Operating Officer from May 2018 until January 2023). Mr. Pierce joined the Company as Senior Vice President, North America, in April 2018. He previously held the position of Chief Executive Officer of BHP Consulting Group, LLC, a sales, marketing and leadership consulting firm that provided consulting services to the Company from May 2017 through March 2018. From 2015 to 2017, Mr. Pierce was Managing Director of the Americas for Aristocrat Technologies, Inc. He was Chief Revenue Officer for the gaming division of Scientific Games Corporation from 2012 to 2015 and held various other roles within Scientific Games from 1991 to 2010, including Senior Vice President of Marketing and President of Scientific Games Racing. From 2010 to 2012, Mr. Pierce was the President and Chief Business Development Officer of Sportech PLC, a U.K.-based gaming equipment and systems supplier. He is currently a Member of the Advisory Board of Leading Edge Ventures, a Wilmington, Delaware-based venture capital fund, as well as an Advisory Board Member of the Horn Entrepreneurial Program at the University of Delaware. He received his BA from the University of Delaware and is a graduate of the Columbia Business School Senior Executive Program. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> James Richardson </b> has been our Chief Financial Officer since January 2025. From 2019 through 2024, Mr. Richardson was employed by Manchester Airports Group as Group Commercial Finance Director and Finance Director of London Stansted and East Midlands Airports, where he contributed significantly to a host of financial, commercial and operational achievements. From 2017 until 2019, Mr. Richardson served as Global Online Finance Director of William Hill plc, one of the world’s leading gaming and betting companies, overseeing the £600 million online betting and gaming business. His leadership was instrumental in delivering substantial multi-territory growth and successfully reorganizing the business to align with strategic objectives. He also served as CFO for Dollar Financial Corp’s UK division, and as CFO for the UK and European divisions of Global Payments Inc., a NASDAQ-listed financial services provider. Earlier in his career, he worked at HSBC Plc, focusing on strategy, mergers and acquisitions, leading the sale of their merchant services business to Global Payments Inc. Mr. Richardson, a Chartered Accountant (FCA, ICAEW), began his career at PricewaterhouseCoopers LLP. He is a graduate of the University of Hull, United Kingdom. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Simona Camilleri </b> has been our General Counsel since July 2024. Dr. Camilleri has an extensive background in the legal and compliance field, holding various leadership roles at companies such as Sportingtech (March 2022 to May 2024), Casumo (August 2020 to January 2022), Payhound and Booming Games (2016-2020), the Betclic Everest Group (2011 to 2016), and UK Counsel for Scientific Games, Global Draw, and Games Media (2006 to 2011). Additionally, she has served on the Board of Gaming Malta and as an Executive Committee Member (Chairperson) for the Remote Gaming Business Section of the Malta Chamber of Commerce. She obtained an LLM in Commercial Law from University College London, after having been awarded a Chevening Scholarship by the British Foreign and Commonwealth Office in 2005. She holds a Doctor of Laws degree and a Bachelor of Arts in Law Sociology from the University of Malta. She was admitted to the bar in Malta in 2004 and to the Roll of Solicitors of England and Wales in 2007, and again in 2024. She is a member of the Malta Chamber of Advocates and the Law Society of England Wales. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 12; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 7 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Board of Directors </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board is comprised of seven directors, each of whom is a nominee for election at the Annual Meeting. During the fiscal year ended December 31, 2024, the Board met six (6) times and all directors attended at least 75% of the total number of meetings of the Board and committees of the Board on which they served. We do not have a policy regarding director attendance at annual meetings, but encourage directors to attend if possible. All of the directors then serving on the Board attended our 2024 virtual annual meeting of stockholders. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Director Independence </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> NASDAQ listing standards require that a majority of the Board be independent. An “independent director” is defined under the NASDAQ rules generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the Board, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our Board has determined that each of our non-employee directors (Messrs. Chambrello, Raphaelson, Saferin, and Vandemore and Mses. Rogers and Tautscher) is an “independent director” as defined in the NASDAQ listing standards and applicable SEC rules. Our independent directors have regularly scheduled meetings at which only independent directors are present. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Leadership Structure and Risk Oversight </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Lead Independent Director. </b> Mr. Chambrello serves as the Board’s Lead Independent Director. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Committees of the Board. </b> The standing committees of the Board consist of an Audit Committee, a Compensation Committee, and a Nominating, Governance and Compliance Committee. Each of the committees is comprised solely of independent directors and reports to the Board. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Audit Committee </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The current members of our Audit Committee are Messrs. Vandemore, Chambrello, and Raphaelson. Mr. Vandemore serves as chairman of the Audit Committee. All members are independent under applicable NASDAQ and SEC rules. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Each member of the Audit Committee is financially literate, and the Board has determined that Mr. Vandemore qualifies as an “Audit Committee financial expert” as defined in applicable SEC rules. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <!-- Field: Page; Sequence: 13; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 8 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We have adopted an Audit Committee charter, available on our website, which details the principal functions of the Audit Committee, including: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> setting clear hiring policies for employees or former employees of the independent auditors; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> overseeing cybersecurity and information security matters; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> setting clear policies for audit partner rotation in compliance with applicable laws and regulations; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> obtaining and reviewing a report, at least annually, from the independent auditors describing the firm’s internal quality-control procedures; any material issues raised by the most recent internal quality-control review, or peer review, of the firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years, respecting one or more independent audits carried out by the firm, and any steps taken to deal with any such issues; and to assess the independent auditors’ independence, all relationships between the independent auditors and the Company; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to our entering into such transaction; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Audit Committee held eleven (11) meetings during 2024 (essentially monthly) to monitor the controls remediation effort in addition to conducting its regular business. As part of these meetings, the Committee met with the Company’s Interim Chief Financial Officer, who reported to the Committee, providing regular and direct status updates on 1) IT and Financial SOX Remediation and 2) GAAP Accounting Remediation areas identified by the various external third parties engaged leading up to and following the Company’s restatements (filed with the SEC in February 2024). Each of these reports contained timelines for remediation which extended into 2025 (in light of GAAP required testing periods to demonstrate effectiveness of revised controls). Third parties supported management on both 1) the IT and Financial SOX remediation, providing process and controls expertise and support, and 2) the GAAP Accounting Remediation, providing organization structure, training and technical accounting process expertise required within the finance team to achieve remediation. The Committee met with the supporting team leadership during its sessions for updates on the work undertaken with the Company and on remediation status. On a regular basis, the engagement partner of Marcum LLP, the Company’s external auditors, also gave updates on their audit work, including their suggestions to and testing of IT and 404 SOX audit remedial work. In addition, the Committee regularly met with both management and in executive session to discuss the remediation progress, including recruiting of additional personnel as part of the enhancement/restructuring of the finance function. Finally, the Chair of the Committee additionally engaged separately with Marcum LLP, the Interim Chief Financial Officer and other members of management regularly to ensure that he and the other members of Committee were fully informed regarding ongoing operations of the finance department, the remediation work, and regular audit work for 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Compensation Committee </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The current members of our Compensation Committee are Messrs. Saferin, Chambrello and Raphaelson. Mr. Saferin is the chairman of the Compensation Committee. All members are independent under applicable NASDAQ and SEC rules. We have adopted a Compensation Committee charter, available on our website, which details the principal functions of the Compensation Committee, including: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing and approving the compensation of the Company’s executive officers; </span> </td> </tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 14; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 9 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing our executive compensation policies and plans; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> implementing and administering our equity-based remuneration plans; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> assisting management in complying with our SEC filings and annual report disclosure requirements; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> producing a report on executive compensation to be included in our annual proxy statement; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Compensation Committee charter also provides that the Compensation Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and is directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the Compensation Committee will consider the independence of each such adviser, including the factors required by NASDAQ and the SEC. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Compensation Committee held nine (9) meetings during 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Nominating, Governance and Compliance Committee </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The current members of our Nominating, Governance and Compliance Committee are Messrs. Raphaelson and Saferin and Mses. Rogers and Tautscher. Mr. Raphaelson is the chairman of the Nominating, Governance and Compliance Committee. All members are independent under applicable NASDAQ and SEC rules. We have adopted a Nominating, Governance and Compliance Committee charter, available on our website, which details the principal functions of the Nominating, Governance and Compliance Committee, including: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing and making recommendations to the Board annually with respect to the composition, size and needs of the Board; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> developing a pool of potential director candidates in the event of a vacancy on the Board; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing stockholder nominations for candidates to the Board, if any, and any stockholder proposals affecting corporate governance, and making recommendations to the Board accordingly; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> reviewing the size, structure and composition of each committee of the Board and presenting recommendations to the Board for committee membership annually and to fill vacancies as needed; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> evaluating and recommending termination of membership of individual directors in accordance with the Company’s bylaws, for cause or for other appropriate reasons; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> in conjunction with the President and Chief Executive Officer, reviewing planning for the succession to the position of Chairman of the Board and President and Chief Executive Officer and other senior management positions; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> periodically reviewing overall corporate governance principles, procedures and practices of the Company and making recommendations to the Board as appropriate; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> receiving reports on environmental, social and governance matters; </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 15; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 10 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> evaluating and monitoring the Company’s policies and procedures for the use of third-party contractors and customer acquisition; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> monitoring compliance by the Company with its policies, including, but not limited to, the Company’s Whistle Blowing Policy, Insider Trading Policy, Code of Ethics, Anti-Corruption and Bribery Policy, and guidelines regarding conflicts of interest. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Nominating, Governance and Compliance Committee held four (4) meetings during 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Oversight of Cybersecurity </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company maintains a governance structure to address cybersecurity risk. For more information, see Item 1C of our Annual Report. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Consideration of Director Candidates </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Director Qualifications </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board believes that all directors should have the highest personal integrity and have a record of exceptional ability and judgment. The Board also believes that directors should ideally reflect a mix of experience and other qualifications. There is no firm requirement of minimum qualifications or skills that candidates must possess. The Nominating, Governance and Compliance Committee evaluates director candidates based on a number of qualifications, including, without limitation, their independence, judgment, leadership ability, expertise in the industry, experience developing and analyzing business strategies, financial literacy, risk management skills, and, for incumbent directors, his or her past performance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Procedures for Consideration </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Nominating, Governance and Compliance Committee initially evaluates a prospective nominee on the basis of their resume and other background information that has been made available. A member of the Nominating, Governance and Compliance Committee will contact for further review those candidates who the committee believes are qualified, may fulfill a specific Board need and would otherwise make a strong contribution to the Board. If, after discussions with the candidate and other reviews and consideration as may be necessary or appropriate, the Nominating, Governance and Compliance Committee believes that it has identified a qualified candidate, it will make a recommendation to the Board, which ultimately determines each slate of director nominees to be proposed to stockholders and ultimately determines when and how to fill vacant Board seats between stockholder elections. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Candidates Recommended by Stockholders </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The policy of our Nominating, Governance and Compliance Committee is to consider recommendations for candidates for director nominees that are properly submitted by stockholders. Any stockholder recommendations for consideration by the Nominating, Governance and Compliance Committee should include the candidate’s name; biographical information; business and residence addresses; resume; information regarding any relationships between the candidate and the Company within the last three years; a description of all arrangements between the candidate and the recommending stockholder and any other person by which the candidate is being recommended; a written indication of the candidate’s willingness to serve on the Board; any other information required to be provided under the section of this document entitled “Other Matters – Stockholder Proposals”, the Company’s bylaws and applicable securities laws and regulations; and a written indication of willingness to provide such other information as the Nominating, Governance and Compliance Committee may reasonably request. The Nominating, Governance and Compliance Committee suggests that any stockholder recommendations address, among other matters, how the candidate would qualify for service as a director based on the following criteria in particular: independence, judgment, leadership ability, expertise in the industry, experience developing and analyzing business strategies, financial literacy and risk management skills. There are no differences in the manner in which the Nominating, Governance and Compliance Committee evaluates candidates for director recommended by a stockholder, and other director candidates. The Nominating, Governance and Compliance Committee identifies candidates for future Board openings on an ongoing basis in the ordinary course of its business, and any candidates recommended by stockholders would be considered in addition to other candidates known to the Nominating, Governance and Compliance Committee. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 16; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 11 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Procedures for Contacting Directors </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board has established a process for stockholders to send communications to the Board. Stockholders may communicate with the Board or with a specific director at any time by writing to Inspired Entertainment, Inc., 250 West 57th Street, Suite 415, New York, New York 10107, Attention: Corporate Secretary, or calling +1 (646) 565-3861. We review all messages received and forward messages that reasonably appear to be communications from a stockholder intended to be made to one or more directors about a matter of stockholder interest. Such messages are forwarded as soon as practicable to the particular director to whom they are addressed or, if not so addressed, to the Chairman of the Nominating, Governance and Compliance Committee. Because other appropriate avenues of communication exist for matters that are not of stockholder interest, such as general business complaints or employee grievances, communications that do not relate to matters of stockholder interest are not forwarded to directors. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Governance Principles </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company is committed to building a culture dedicated to ethical business behavior and responsible corporate activity. We believe strong corporate governance is the foundation to delivering on our commitments. It does this by: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (i) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Being committed to having a board which is representative of the different skillsets and the commercial landscape in which we operate; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> (ii) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Having six independent directors out of seven, a lead independent director and entirely independent committees; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> (iii) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Having stock ownership guidelines for directors and executive officers; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> (iv) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Having annual board and committee self-evaluations and annual evaluations of executive officers and having regular executive sessions of independent directors; </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> (v) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Implementing policies to combat unethical business conduct and asking suppliers to comply with our Code of Ethics, as well as maintaining a Whistleblowing Policy that protects employees who raise concerns; and </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span style="font-size: 10pt"> (vi) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Implementing policies and standards for responsible and ethical business practices, financial and compliance controls, including an ISO 9001 compliant Control of External Providers’ policy, an Anti-Corruption Bribery Policy, an Insider Trading Policy, a Conflict of Interest Policy, and an ISO 27001 compliant Information Security Management System, as well as risk-based employee, consultant, vendor, and business partner due diligence coupled with contracting, finance, and audit oversight. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> This is also part of a shared philosophy by the Compensation Committee, which drives the effort to refine and improve alignment of management and stockholder interests. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Stock Ownership Guidelines </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> According to the Company’s stock ownership guidelines, our named executive officers and the non-employee members of our Board are required to hold shares of our common stock with a value at least equal to the following multiple of their annual base salary or cash retainer: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Executive Chairman: 6x annual base salary </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Other executive officers: 3x annual base salary </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Non-employee members of Board of Directors: 5x annual cash retainer </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Under the ownership guidelines, shares counting toward satisfaction of these guidelines include shares owned outright or indirectly held by the individual or by a member of the individual’s immediate family residing in the same household and including through 401(k) plans and shares held in trust for the benefit of the individual and/or the individual’s family as well as shares underlying restricted stock units. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 17; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 12 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Clawback Policy </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In August 2023, the Board adopted a compensation recovery policy as required under Nasdaq’s final rules implementing Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The policy covers our executive officers and subjects their <span style="background-color: white"> incentive-based compensation (i.e., compensation that is </span> granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure) <span style="background-color: white"> to recovery </span> in the event the Company is required to prepare an accounting restatement due to material noncompliance with financial reporting requirements. Prior to adoption of the policy, historic long- and short-term incentive plans adopted by the Compensation Committee contained certain clawback provisions providing that awards may be subject to reduction, cancellation, forfeiture, repayment or recoupment including, without limitation, by reason of a financial restatement, mistake in calculations or other administrative error or to the extent necessary to comply with any clawback, forfeiture or other similar policy adopted by the Board or the Compensation Committee and as in effect from time to time. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <br/> As previously disclosed, the Company identified immaterial errors in its previously reported financial statements for the year ended December 31, 2023 and December 31, 2022 relating to the classification of leases between operating and sales type and immaterial errors relating to capitalization of software project content costs. In accordance with Staff Accounting Bulletin (“SAB”) 99, Materiality, and SAB 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in the Current Year Financial Statements, the Company evaluated the materiality of the errors from qualitative and quantitative perspectives, and concluded that the errors were immaterial to any prior annual or interim financial statements. Notwithstanding this conclusion, the Company revised the consolidated financial statements for these historical years in the Annual Report for the year ended December 31, 2024 in order to correct the errors. Although the errors were immaterial and did not require a clawback analysis under the policy, the Compensation Committee evaluated the effect of the revisions and determined the revised results made no difference for 2022 awards and an immaterial difference to a subset of 2023 awards (equity-based). Accordingly, in light of the immaterial difference, the substantially off-setting impact of the corrections over the historical periods, and the Compensation Committee having exercised negative discretion to reduce cash-based awards in the historical periods, the Compensation Committee concluded that it would not revisit the prior awards. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Audit Committee Report* </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Audit Committee meets regularly with the Company’s management and its independent registered public accounting firm to consider the adequacy of the Company’s internal controls and the objectivity of its financial reporting. In addition, the Audit Committee meets regularly with the Company’s independent registered public accounting firm alone to review the foregoing matters. The Audit Committee selects the Company’s independent registered public accounting firm and periodically reviews its performance and independence. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Audit Committee reviewed and discussed the Company’s audited financial statements for the fiscal year ended December 31, 2024 with management, and discussed with the Company’s independent registered public accounting firm the matters required to be discussed by applicable rules of the Public Company Accounting Oversight Board (the “PCAOB”). Additionally, the Audit Committee reviewed the written disclosures and letter from our independent registered public accounting firm required by the rules of the PCAOB and discussed the independence of the independent registered public accounting firm under applicable PCAOB and SEC requirements. Based upon such reviews and discussions, the Audit Committee recommended to the Board that the Company’s audited financial statements for the year ended December 31, 2024 be included in the Company’s Annual Report on Form 10-K for such year, for filing with the SEC. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Respectfully submitted, </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Audit Committee of the Board of Directors </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> /s/ John M. Vandemore, Chairman </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> /s/ Michael R. Chambrello </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> /s/ Ira H. Raphaelson </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> <i> The information contained in this Audit Committee Report shall not be deemed to be “soliciting material” or “filed” or incorporated by reference in future filings with the SEC, or subject to the liabilities of Section 18 of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), except to the extent the Company specifically requests that the information be treated as soliciting material or specifically incorporates it by reference into a document filed under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act. </i> </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 18; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 13 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Code of Ethics </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We have adopted a Code of Ethics applicable to our directors, officers and employees. Copies of our Code of Ethics and our Audit Committee, Compensation Committee and Nominating, Governance and Compliance Committee charters are available on our website at www.inseinc.com. Amendments to, or waivers for any of our principal executive officers from the requirements of, our Code of Ethics, if any, will be disclosed on our website at www.inseinc.com or in our reports filed with the SEC. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Insider Trading Policy </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Under our <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBQb2xpY2llcyBhbmQgUHJvY2VkdXJlcwA_" id="xdx_902_eecd--InsiderTrdPoliciesProcAdoptedFlag_dbT_c20240101__20241231_zHkGW0nj7cOh"> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" format="ixt:booleantrue" id="Fact000013" name="ecd:InsiderTrdPoliciesProcAdoptedFlag"> insider trading policy </ix:nonNumeric> </span> , all employees (including officers) and members of the Board are prohibited from purchasing shares on margin, from engaging in short sales, and from buying or selling puts, calls or other derivatives in respect of our securities. Although we discourage speculative hedging transactions, we do permit long-term hedging transactions that are designed to protect the individual’s investment in our securities. Any hedge must be for at least six months and relate to stock or options held by the individual. All hedging transactions must be pre-cleared pursuant to our insider trading policy. The Company has not approved any hedging transactions and does not expect to do so. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Employees certify their receipt of on-boarding and periodic training in the foregoing as well as other corporate controls policies. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We are committed to promoting high standards of ethical business conduct and compliance with applicable laws, rules and regulations. As part of this commitment, we have adopted our insider trading policy governing the purchase, sale, and/or other dispositions of our securities by our directors, officers, employees that we believe is reasonably designed to promote compliance with insider trading laws, rules and regulations, and the exchange listing standards applicable to us. A copy of our insider trading policy was filed as Exhibit 19.1 to our Annual Report. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_003"/> EXECUTIVE COMPENSATION </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Executive Compensation Oversight and Objectives </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our executive compensation program is overseen by the Compensation Committee. The Compensation Committee has developed the following goals for our executive compensation program: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> to attract and retain key executive talent by providing competitive compensation; </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> to reward executive officers based upon the achievement of Company performance goals and individual performance goals; and </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> to align the interests of executive officers with those of our stockholders. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Compensation Consultant </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Compensation Committee retains Frederic W. Cook Co., Inc. (“FW Cook”) as its independent compensation consultant. Representatives of FW Cook regularly attend Compensation Committee meetings and communicate with the Chair of the Compensation Committee between meetings. FW Cook reports directly to the Compensation Committee and the Compensation Committee oversees the fees paid to it for its services. FW Cook provides the Compensation Committee with independent and objective guidance on a variety of matters related to our executive and director compensation programs and general compensation and benefits matters. FW Cook does not provide any consulting services to the Company beyond its role as a consultant to the Compensation Committee. The Compensation Committee conducts an assessment of the independence of its compensation consultant annually, pursuant to SEC rules and, following its most recent assessment, concluded that no conflict of interest exists that would prevent FW Cook from serving as an independent consultant to the Compensation Committee. During 2024, FW Cook provided the following services to the Compensation Committee: (1) prepared a compensation risk assessment; (2) provided advice on executive compensation levels for Executive Chairman, Chief Executive Officer and Chief Financial Officer; (3) advised the Compensation Committee regarding clawback policy including in connection with the Company’s financial restatements (included in our Form 10-K/A for the fiscal year ended December 31, 2022) which were filed with the SEC in February 2024; and (4) advised the Compensation Committee on executive compensation trends and regulatory developments generally. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 19; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 14 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Benchmarking </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In evaluating each element of compensation for our executive officers and senior officers, the Compensation Committee reviewed and benchmarked compensation levels against competitive market data developed by FW Cook. In general, market data developed by FW Cook was comprised of peer group proxy compensation data, together with compensation data by functional position derived from general industry surveys. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The proxy peer group composition is reviewed and approved by the Compensation Committee after obtaining advice from FW Cook. Key criteria for inclusion include similar size, industry focus, scope and complexity of business as well as companies with which we compete for executive talent. The current peer group is as follows: Accel Entertainment, Inc. (NYSE:ACEL), Agilysys, Inc. (NASDAQ:AGYS), Century Casinos, Inc. (NASDAQ:CNTY), Everi Holdings Inc. (NYSE:EVRI), Full House Resorts, Inc. (NASDAQ:FLL), GAN Limited (NASDAQ:GAN), Golden Entertainment, Inc. (NASDAQ:GDEN), IMAX Corporation (NYSE:IMAX), LiveOne, Inc. (NASDAQ:LVO), PlayAGS, Inc. (NYSE:AGS), Reservoir Media, Inc. (NASDAQ:RSVR), Rush Street Interactive, Inc. (NYSE:RSI), Synchronoss Technologies, Inc. (NASDAQ:SNCR) and Turtle Beach Corporation (NASDAQ:TBCH). <br/> <br/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Compensation Risk Assessment </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We believe that the performance goals and incentive plan structures generally established under the Company’s executive, annual and long-term incentive programs are not reasonably likely to have a material adverse effect on the Company. Additionally, the Compensation Committee works with management to ensure that compensation incentives are structured in a manner to minimize risk of non-compliance. The approved goals under our incentive programs are consistent with our financial operating plans and strategies, and these programs are discussed and reviewed by the Compensation Committee as well as with an independent compensation consultant. The Company’s compensation systems are balanced, rewarding both short-term and long-term performance, and its performance goals are team-oriented rather than individually focused, and include measurable factors and objective criteria. The Compensation Committee is actively engaged in setting executive compensation systems, monitoring those systems during the year and using discretion in making rewards, as necessary. Both in reliance on its independent compensation consultant’s report and on its own judgments, the Compensation Committee believes that the Company’s compensation policies and practices for its employees do not encourage risk taking that is reasonably likely to have a material adverse effect on the Company. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Named Executive Officers </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The named executive officers of the Company (the “Named Executive Officers”) for 2024 were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1pt solid; width: 30%; text-align: justify"> <span style="font-size: 10pt"> Named Executive Officer </span> </td> <td style="width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; width: 68%; text-align: justify"> <span style="font-size: 10pt"> Position </span> </td> </tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: justify"> <span style="font-size: 10pt"> A. Lorne Weil </span> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Executive Chairman </span> </td> </tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: justify"> <span style="font-size: 10pt"> Brooks H. Pierce </span> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> President and Chief Executive Officer </span> </td> </tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: justify"> <span style="font-size: 10pt"> Marilyn Jentzen </span> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Former Interim Chief Financial Officer </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Ms. Jentzen served as Interim Chief Financial Officer from December 2023 through December 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 20; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 15 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Executive Compensation Elements </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The principal elements of the compensation program for our executive officers consist of: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> base salary; </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> short-term cash bonus awards; </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> long-term equity awards; </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> personal benefits; and </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> termination and change in control provisions. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Base Salary </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Base salary levels are reviewed by the Compensation Committee on an annual basis and as circumstances warrant. In determining base salary levels, the Compensation Committee considers market competitive information, internal pay equity, individual responsibilities and performance assessments. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Incentive-based Compensation </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Overview of Short- and Long-Term Incentive Plans </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company’s short-term incentive plan (STIP) is based on attainment of Adjusted EBITDA (as defined below in the “Pay versus Performance” section) before the inclusion of bonuses under the STIP (“Adjusted EBITDAB”). The STIP for 2024 had various target eligibility levels across multiple tiers of management levels ranging from 10% to 120% of base salary depending on corporate performance, business segment performance, and individual performance objectives. Bonus eligibility for the Company’s executive officers for 2024 was based on corporate performance criteria, except for Ms. Jentzen (our Interim CFO), whose bonus was solely based on remediation of material accounting and SOX weaknesses. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company’s long-term incentive plan (LTIP) contemplates an aggregate award of restricted stock units with a value equal to a percentage of base salary depending on management levels and ranging from 10% to 100%. Half of the awards are time-vested and half are subject to performance criteria. The time-vested restricted stock units vest as to 1/3 in each year beginning in the year of grant, and performance-based restricted stock units vest on December 31 of the third year after the grant, provided that such shares are earned by meeting the performance criteria set at the time of the grant for the initial year. The performance criteria are based on Adjusted EBITDAB targets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Short-Term Cash Bonus Awards </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> 2024 Short-Term Cash Bonus Awards </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As part of the STIP adopted by the Compensation Committee, the named executive officers (other than Ms. Jentzen) were eligible to receive performance-based cash bonuses for 2024 based on a formula that involved attainment of the Company’s financial performance metrics. The target bonus opportunity for Mr. Weil for 2024 was equal to 120% of his base salary and his maximum bonus opportunity was equal to 240% of his base salary. The target bonus opportunity for Mr. Pierce was equal to 110% of his base salary and his maximum bonus opportunity was equal to 220% of his base salary. Ms. Jentzen was not a participant in the STIP but was eligible to receive a bonus, at the discretion of the Compensation Committee, of up to $100,000, conditional upon substantial remediation of the Company’s material accounting and SOX weaknesses. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In adopting the budget and bonus structure for 2024, the Compensation Committee, on recommendation of the executive team, adopted a budget with an Adjusted EBITDAB target of $115.8 million (converted from GBP, our functional currency, based on prevailing exchange rate on approval date). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 21; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 16 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In February 2025, the Compensation Committee reviewed the preliminary Adjusted EBITDAB results for 2024 (which reflected attainment of approximately 89% of the target) and the performance of the executive officers and other eligible employees. Based on such evaluation, and management’s recommendation, the Compensation Committee approved awards equal to 38.55% of each eligible participant’s target award opportunity for attainment of the corporate performance target for the year (subject to adjustment until the financial statements to be included in the Annual Report were finalized). In March 2025, the Compensation Committee reviewed the effect of certain immaterial revisions to historical financial statements (which were identified while the Company was preparing its 2024 financial statements) as well as the impact on the amount of Adjusted EBITDAB previously reported to the Compensation Committee for 2024. Following its review, the Compensation Committee concluded that, in light of the substantially off-setting impact of the corrections over the historical periods (from the re-allocation from 2024 to earlier years of certain revenues previously included for 2024), it would not revisit the awards approved for 2024. In the case of Ms. Jentzen, whose award was solely based upon substantial remediation of material accounting and SOX weaknesses, the Compensation Committee approved her full award potential ($100,000). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Additional Criteria for Finance Team </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> For 2024, the Compensation Committee adopted additional performance criteria for members of the finance team, with regards to 50% of their eligible STIP (including any maximum STIP), based on (i) substantial remediation of material accounting and SOX weaknesses by year end; and (ii) achievement of proficiency training in U.S. GAAP accounting, each of which was subject to management’s recommendation as to achievement and the Compensation Committee’s determination (save in respect of the Interim CFO for whom the entire bonus potential (of $100,000) was dependent on substantial remediation of material accounting and SOX weakness by December 31, 2024 to be assessed based on recommendations from management and exercising Compensation Committee discretion, as to whether the criteria being met. In approving bonuses for the finance team members, the Compensation Committee determined that significant improvements had been made in achieving the established criteria. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> For 2025, the Compensation Committee determined that members of the finance team will have the opportunity to be awarded an additional 10% STIP bonus, conditioned upon the Company’s external auditor issuing an unqualified audit opinion without any material weaknesses/significant deficiencies. The Compensation Committee determined that such additional bonus opportunity was appropriate, given the Company’s ongoing commitment to improve U.S. GAAP accounting controls and in particular the finance team’s efforts in achieving remediation of material weaknesses and deficiencies. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Long-Term Equity Awards </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In February 2024, the Compensation Committee resolved to award RSUs to management based on a percentage of base salary (100% in the case of the executive officers) and a formula price, subject to certain caps and a different formula price methodology in the case of Mr. Weil), half of which will be time vested and half of which will have performance criteria (as measured by Adjusted EBITDAB), with time-vested shares vesting 1/3 each year beginning in year of grant, and performance shares vesting on December 31 of the third year after the grant, provided that such shares are earned by meeting the performance criteria set at the time of the grant for the initial year. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Although there is an overlap between the metrics used in the Company’s short-term and long-term incentives, the Compensation Committee believes Adjusted EBITDAB is a key indicator of both short- and long-term performance outcomes. The Compensation Committee takes this overlap into consideration in determining compensation incentives of Company executives, to attempt to achieve an appropriate level of focus across the key drivers of the Company’s performance. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Recognizing the significant challenges in setting reliable, long-term performance goals, the Compensation Committee approved a one-year performance period for the performance awards to maintain the rigor and effectiveness of the program in incentivizing management. The Compensation Committee will continue to review market conditions and evaluate whether longer performance periods for future equity awards would be appropriate. </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company calculated the value of the Common Stock for the formula awards at $15.73, in comparison to the closing price of $9.17 of our stock on the date of grant. The formula amount was determined based on the highest of (i) the 20-trading day average price prior to the grant date, (ii) the 20-trading day average preceding the highest price for the prior year, and (iii) 80% of the formula price at which the prior year’s formula awards were granted.  In Mr. Weil’s case, pursuant to the terms of his employment agreement, the formula price was determined to be $9.18 (the closing price prior to the date of grant) and the number of shares was capped at 80,000. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In February 2025, as discussed in the section above relating to STIP awards for 2024, the Compensation Committee reviewed the preliminary Adjusted EBITDAB results for 2024 and determined that the performance level attained equated to approximately 38.55% of target award eligibility. In the case of Messrs. Weil and Pierce, the Compensation Committee approved amounts equal to 60% of their target awards to partially exclude them from the negative effect of the anomalous under-performance of the virtuals segment for the year (all other segments meeting or exceeding 100% performance levels). In arriving at its conclusion, the Compensation Committee considered its historic exercise of negative discretion in prior years, the role of the most senior management in the remediation of material controls issues during the years, their role in the positive achievements of other business units, and the substantial remedial steps undertaken to improve the virtuals business model prospectively. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 22; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 17 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In March 2025, after reviewing the updated level of Adjusted EBITDAB for 2024 and the effect of certain immaterial revisions to historical financial statements, as discussed in the section above, the Compensation Committee determined that, in light of the substantially off-setting impact of the corrections over the historical periods, not to revise these awards. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> <i> Grants of Certain Equity Awards </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company’s stock-based awards consist of RSUs (time-based and performance-based). Accordingly, we do not have a policy or practice relating to the timing for approving stock option grants. The Compensation Committee has determined that granting RSUs rather than options allows it to better conserve the shares allotted for incentive purposes under the shareholder approved plan. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Personal Benefits </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The executive officers of the Company who are U.S.-based (Messrs. Weil and Pierce) are offered executive-tiered life insurance (at 4 times base salary) and health insurance and participation in a broad-based 401(k) plan that provides matching contributions of up to 4% of compensation (subject to IRS annual maximums). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The executive officers of the Company who are U.K.-based (Mr. Richardson and Ms. Camilleri), receive U.K. market-related benefits, including executive-tiered health insurance, life insurance and a defined contribution pension scheme carrying a 15% employer contribution. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company also provides tax equalization benefits for dual-location employees (for 2024, Mr. Pierce and Ms. Jentzen). Ms. Jentzen, who was on full-time assignment in our U.K. offices for a portion of the year, received a monthly supplement of $3,600 (net of taxes) through August 2024 and was provided with a Company leased vehicle. She also received lump sum relocation support payments (net of taxes) of $15,000 and $5,000 (the second upon her relocation back to the U.S.). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Employment Agreements, including Termination and Change in Control Provisions </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The employment service agreements entered into with our Named Executive Officers establish the overall framework for each such officer’s compensation, including base salary and target and maximum bonus amounts. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In January 2025, the Company entered <span style="background-color: white"> into addendums to its employment agreements with each of Messrs. Weil and Pierce, which, as described below, extended their term of employment by one year, increased their base salary rates and increased their annual target bonus opportunity. </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Employment Agreement with A. Lorne Weil, Executive Chairman </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On October 9, 2020, the Company entered into an employment agreement with A. Lorne Weil, the Company’s Executive Chairman, which replaced his prior agreement. The employment agreement, which was amended June 21, 2021, January 12, 2023 and January 29, 2025, has a term ending December 31, 2028. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Pursuant to the terms of Mr. Weil’s addendum dated January 29, 2025 (with an effective date of January 1, 2025), Mr. Weil’s base salary rate was increased from $800,000 to $950,000 and his annual target bonus opportunity was increased from 120% to 130% of his annual salary (his maximum bonus opportunity is equal to two times his target bonus). Mr. Weil is eligible to receive formula awards of RSUs under the Company’s LTIP program in amounts up to 80,000 RSUs for any fiscal year. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 23; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 18 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Mr. Weil’s employment agreement provides for special equity grants – he was awarded 100,000 RSUs upon execution of his employment agreement in October 2020 (which was subject to a time-based service condition through June 30, 2021) and received an additional 750,000 RSUs, subject to stockholder approval of the 2021 Omnibus Incentive Plan which was obtained at the 2021 Annual Meeting of Stockholders. The 750,000 RSUs, as modified under the first addendum to his employment agreement, were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7.1pt; text-align: justify; text-indent: 32.65pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Time-Based RSUs — 165,000 time-based RSUs as to which 80,000 RSUs vested on December 31, 2023 and 85,000 RSUs vested on December 31, 2024. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Adjusted EBITDA Based RSUs — 187,500 RSUs, in increments of 62,500 RSUs, for each of the calendar years from 2022 through 2024, subject to the Company’s achievement of Adjusted EBITDA targets, consistent with the Company’s STIP, provided proration of the award would begin upon achievement of 70% of the annual target. In addition, for each year in which the Compensation Committee determines that the STIP target has been exceeded, the excess EBITDA would be applied to the subsequent year in determining whether Mr. Weil has met the subsequent year’s EBITDA target. The target for the first tranche (2022) was met and subsequent tranches (2023 and 2024) after factoring carryover for performance in excess of the target for prior years. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Stock Price Based RSUs – 397,500 RSUs that may be earned by meeting certain stock price targets (as measured over a consecutive 45-day calendar period) as follows: 80,000 RSUs — $6.25 stock price target; 85,000 RSUs — $8.25 stock price target; 135,000 RSUs — $15.00 stock price target; 50,000 RSUs — $17.50 stock price target; and 47,500 RSUs — $20.00 stock price target. The stock price targets applicable to the first three increments were attained. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Mr. Weil was awarded a further special equity grant under the second addendum, which was subject to approval by the stockholders of the Company of the 2023 Omnibus Incentive Plan at the 2023 Annual Meeting, of an aggregate of 250,000 RSUs, comprised of 125,000 Adjusted EBITDA Based RSUs that may be earned in one-third increments for each of the calendar years from 2025 to 2027, and 125,000 Stock Price Based RSUs that may be earned in one-quarter increments by meeting certain stock price targets (as measured over a consecutive 45-day calendar period) ranging from a price target of $15.00 to $22.50. The stock price target applicable to the first increment was achieved in February 2023. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In the event the Company elects to terminate Mr. Weil’s employment without cause, or if Mr. Weil terminates his employment for good reason, Mr. Weil would receive his salary and target bonus amount through the earlier of (i) his contract termination date and (ii) eighteen months (or thirty months if the termination constituted a “change in control termination event” as defined), he would receive a prorated target bonus for the year of termination and his unvested equity awards (excluding his special sign-on RSUs) would remain outstanding subject to potential vesting in accordance with the time, performance or other conditions applicable to the awards. With respect to the special sign-on RSUs (as to which an aggregate of 191,250 Stock Price RSUs and 125,000 Adjusted EBITDA RSUs remain unvested), if Mr. Weil’s employment terminates prior to the end of the agreement, the unvested portion would lapse in circumstances other than death, a “change in control termination event” or if the Company’s stock is no longer publicly traded, in which case all or a portion of the outstanding balance would vest. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In addition, in accordance with the terms of Mr. Weil’s agreement, term life insurance coverage was obtained in December 2020 in order to provide Mr. Weil with a death in service benefit equal to four times his base salary, which is equivalent to the coverage offered to other executives of the Company under a group policy. The annual cost of the coverage to the Company is approximately $74,000. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Under the employment agreement, Mr. Weil will remain subject to certain covenants, including, among other things, a covenant not to enter into a directly competing business or solicit employees of the Company for a period of eighteen months after termination of his employment (or twelve months in the event of a “change in control termination event”), as well as a covenant not to disclose certain confidential information of the Company. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 24; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 19 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Employment Agreement with Brooks H. Pierce, President and Chief Executive Officer </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On February 17, 2020, the Company entered into an employment agreement with Brooks H. Pierce, the Company’s President and Chief Executive Officer, which replaced his prior agreement. The employment agreement was amended on July 21, 2021, January 13, 2023 and January 29, 2025. The agreement, as amended, has a term of employment through December 31, 2027. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Pursuant to the terms of Mr. Pierce’s addendum dated January 29, 2025 (with an effective date of January 1, 2025), Mr. Pierce’s base salary rate was increased from $585,000 to $650,000, and his annual target bonus opportunity was increased from 110% to 120% of base salary (his maximum bonus opportunity is equal to two times his target bonus). Mr. Pierce is also eligible to receive incentive and equity-based compensation and any other benefits determined by the Compensation Committee, including participation in the Company’s long-term incentive plan available for senior executives. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Mr. Pierce’s agreement provided for him to receive a special sign-on equity grant of an aggregate of 200,000 RSUs (which was awarded on February 17, 2020), one-half in the form of time-based RSUs (vesting as to 75,000 on December 31, 2022 and 25,000 on December 31, 2023) and one-half in the form of performance-based RSUs (25,000 RSUs per year for the years 2020 through 2023, based on the Company’s achievement of annual adjusted EBITDA targets). With respect to the performance-based tranches, Mr. Pierce earned a portion of the tranches for 2020 and 2023 and the full amounts for 2021 and 2022. He received an additional special sign-on grant of 75,000 time-based RSUs in July 2021 in connection with an amendment to extend the term of his agreement, which vested on December 31, 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Mr. Pierce received a further grant of 125,000 Adjusted EBITDA Based RSUs, which was subject to approval by the stockholders of the Company of the 2023 Omnibus Incentive Plan at the 2023 Annual Meeting, half of which may be earned in 2025 and the remaining half of which may be earned in 2026 based on the Company achieving targets based on adjusted EBITDA for such years. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In the event the Company elects to terminate the agreement other than for cause, or if Mr. Pierce terminates the agreement for good reason, Mr. Pierce will receive accrued benefits, salary for 12 months and a prorated bonus for the year of termination (or 18 months in the event of a change in control transaction, plus 1.5 times target bonus), and his outstanding equity awards will vest in accordance with the terms set forth in the agreement. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Under the employment agreement, Mr. Pierce will remain subject to certain covenants, including, among other things, a covenant not to enter into a directly competing business or solicit employees of the Company for a period of one year after termination of his employment, as well as a covenant not to disclose certain confidential information of the Company. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Employment Agreement with Marilyn Jentzen, Former Interim Chief Financial Officer </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Ms. Jentzen was appointed Interim CFO in December 2023 and served in such capacity through December 2024. Ms. Jentzen was initially employed under an agreement dated November 2023, which was replaced by an agreement dated April 12, 2024. Under the new agreement, which provided for a term of employment through December 31, 2024 and assignment in our UK offices, Ms. Jentzen was paid at a weekly base salary rate of $17,500 (increased from prior rate of $500,000 per annum effective April 8, 2024) and received the following relocation support elements: (i) accommodation supplement of $3,600 per month, net of taxes; (ii) a one-time relocation payment of $15,000, net of taxes; (iii) a one-time return payment of $5,000, net of taxes; (iv) a hire vehicle and all associated running costs, except for fuel; (v) one business class US/UK return flight during the period of employment; (vi) preparation and filing of UK self-assessment tax returns; and (vii) a UK visa sponsorship and all associated visa costs. Ms. Jentzen was also eligible for a bonus of up to $100,000 for 2024, conditioned upon substantial remediation of material accounting and SOX weaknesses. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> On November 5, 2024, the Company entered into an amendment to Ms. Jentzen’s employment agreement under which she agreed to remain with the Company following her role as Interim CFO for a further period in the role of Transformation Officer (from January 1, 2025 through May 31, 2025). At Ms. Jentzen’s election, her employment ended on an earlier basis on April 4, 2025 and following completion of the filing of the Company’s Annual Report. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> Indemnification Agreements </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company has entered into indemnification agreements with all of its directors and executive officers pursuant to which such individuals are indemnified by the Company to the fullest extent permitted under Delaware law. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <!-- Field: Page; Sequence: 25; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 20 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Summary Compensation Table </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The following table sets forth information concerning compensation awarded to, earned by or paid to our Named Executive Officers for the years specified. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"> <span style="font-size: 10pt"> <b> Name and Principal Position </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Year (1) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Salary ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Bonus ($) (2) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Stock Awards ($) (3)(4) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Option Awards ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Nonequity Incentive Plan Compensation (5) ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> All Other Compensation (6) ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Total ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 23%"> <span style="font-size: 10pt"> A. Lorne Weil </span> </td> <td style="width: 1%"> </td> <td style="width: 6%; text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 800,000 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> 86,674 </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"> 1,391,725 </p> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 283,392 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 105,734 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 2,667,525 </span> </td> <td style="width: 1%"> </td> </tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"> <span style="font-size: 10pt"> <i> Executive Chairman </i> </span> </td> <td style="vertical-align: bottom"> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 787,500 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 3,238,812 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 384,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 103,922 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 4,514,234 </span> </td> <td style="vertical-align: bottom"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 750,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,658,317 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,215,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 128,876 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 3,752,193 </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td> <span style="font-size: 10pt"> Brooks H. Pierce </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 585,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> 58,099 </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 341,032 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 189,961 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 150,017 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,324,109 </span> </td> <td> </td> </tr> <tr style="background-color: white"> <td style="vertical-align: bottom"> <span style="font-size: 10pt"> <i> President and CEO </i> </span> </td> <td style="vertical-align: bottom"> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 570,000 </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,009,920 </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 257,400 </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 111,016 </span> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,948,336 </span> </td> <td style="vertical-align: bottom"> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 525,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 905,165 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 708,750 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 149,455 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 2,288,370 </span> </td> <td> </td> </tr> <tr style="background-color: #CCEEFF"> <td style="vertical-align: bottom"> <span style="font-size: 10pt"> Marilyn Jentzen </span> </td> <td style="vertical-align: bottom"> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 799,615 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 100,000 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 291,478 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 402,255 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 1,593,348 </span> </td> <td style="vertical-align: bottom"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> <span style="font-size: 10pt"> <i> Former Interim CFO </i> </span> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"/> <td style="text-align: justify"/> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt; background-color: white"> Ms. Jentzen (who served as Interim CFO from December 2023 to December 2024) was not a named executive officer for 2022 or 2023 (and, accordingly, her compensation is shown only for 2024). </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (2) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The amounts shown as bonuses for Mr. Weil and Mr. Pierce reflect the amounts approved for them in excess of the amounts that met the performance targets under the STIP bonus program for 2024 which are shown in footnote 5 below. The bonus approved for Ms. Jentzen for 2024 was contingent upon substantial remediation of material accounting and SOX weaknesses. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (3) </span> </td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The stock awards for 2024 consist of (i) formula awards of time-based RSUs and performance-based RSUs to each of the Named Executive Officers, and (ii) a tranche of performance-based RSUs subject to 2024 performance criteria which was approved in a previous year for Mr. Weil pursuant to his employment agreement but as to which the accounting grant date for such tranche did not occur until 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The values shown reflect the grant date fair value of the awards computed in accordance with FASB ASC Topic 718. For the time-based RSUs and performance-based RSUs, the values were determined by multiplying the number of shares subject to the awards by the closing price of the Common Stock on the grant date and, with respect to the performance-based RSUs (as to which the number of RSUs eligible to vest depends on the performance level attained), the amount reflects the Company’s assessment at the time of grant as to the probable outcome of the performance condition, which was determined to be 100% of the target amount. If the formula performance-based RSUs (which had a maximum opportunity of 200%) had instead been valued assuming attainment of the maximum performance level, the grant date fair value of such RSUs would have been as follows: Mr. Weil, $733,600, Mr. Pierce, $341,032 and Ms. Jentzen, $291,478. The performance RSUs awarded to Mr. Weil as sign-on RSUs are capped at 100% of the target amount. In the case of Ms. Jentzen, the stock awards reflected are no longer outstanding (such awards were canceled during 2024). For additional information, see our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. </p> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 26; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 21 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (4) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt; background-color: white"> The amount included in the historical stock awards column for 2023 for Mr. Weil has been revised to include $80,475 which reflects the incremental fair value associated with a modification of certain stock price RSUs that were granted to Mr. Weil in 2021. The modification related to an extension of the term of Mr. Weil’s employment agreement which extended the period during which his stock price RSUs remain eligible to vest. The incremental fair value resulting from such modification was inadvertently omitted. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (5) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The nonequity incentive compensation awards shown reflect amounts earned under the Company’s STIP bonus program and paid after year end. The payout level shown reflects approximately 29.52% of the Named Executive Officer’s target bonus for fiscal 2024 (an incremental amount was approved, as shown in footnote 2 above, resulting in an aggregate payout level of approximately 38.55%, as described in the section above under “2024 Short-Term Cash Bonus Awards”), 40% for fiscal 2023 and 135% for fiscal 2022, based on the attainment of performance targets for the applicable year. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (6) </span> </td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The amounts shown under “All Other Compensation” for 2024 include the following: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> (i) Mr. Weil, $13,800 in matching contributions allocated to a defined contribution plan, $74,037 for term life insurance coverage, $404 for life insurance premiums under a group policy providing supplemental coverage (commenced December 1, 2024), $13,493 relating to health insurance costs and $4,000 provided as a health insurance benefits supplement; </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> (ii) Mr. Pierce, $13,800 in matching contributions allocated to a defined contribution plan, $4,625 for life insurance premiums, $9,672 relating to health insurance costs, $4,000 provided as a health insurance benefits supplement, $1,725 for U.K. tax return preparation costs and tax equalization in the estimated amount of $116,195; and </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> (iii) Ms. Jentzen, $20,000 in net payments provided for relocation support, $27,673 in net payments for housing support in the U.K., $18,288 for grossing up the net relocation and housing support payments, $15,903 for providing an automobile in the U.K. (reflecting the cost of the lease), $20,228 in additional relocation costs (including airline travel for relocation back to the U.S.), $1,403 for payment of attorney fees, $4,203 for U.K. tax return preparation costs, $6,018 for life insurance premiums and tax equalization in the estimated amount of $288,539. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> With respect to the health insurance costs specified above for each of Messrs. Weil and Pierce, the amounts reflect the incremental cost to the Company of providing health insurance coverage to these executives in comparison to the amounts incurred for coverage that’s available generally to the Company’s salaried employees. </p> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Outstanding Equity Awards at 2024 Fiscal Year-End </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The following table sets forth information concerning outstanding equity awards held by our Named Executive Officers (or by a transferee) as of December 31, 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="18" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Option Awards </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Stock Awards <sup> (1)(2)(3)(4) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"> <span style="font-size: 10pt"> <b> Name </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Number of <br/> securities <br/> underlying <br/> unexercised <br/> options <br/> (#) <br/> exercisable </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Number of <br/> securities <br/> underlying <br/> unexercised <br/> options <br/> (#) <br/> unexercisable </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Equity <br/> incentive <br/> plan <br/> awards: <br/> number of <br/> securities <br/> underlying <br/> unexercised <br/> unearned <br/> options <br/> (#) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Option <br/> exercise <br/> price <br/> ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Option <br/> expiration <br/> date </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Number <br/> of shares or <br/> units of stock <br/> that have <br/> not vested <br/> (#) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Market <br/> value <br/> of shares <br/> or units of <br/> stock that <br/> have not <br/> vested <br/> ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Equity <br/> incentive <br/> plan awards: <br/> number of <br/> unearned <br/> shares, units <br/> or other rights <br/> that have not <br/> vested <br/> (#) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Equity incentive <br/> plan awards: <br/> market or <br/> payout value of <br/> unearned shares, <br/> units or other <br/> rights that <br/> have not vested <br/> ($) </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 10%"> <span style="font-size: 10pt"> A. Lorne Weil <sup> (3) </sup> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 70,720 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 640,016 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 191,250 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 7%; text-align: right"> <span style="font-size: 10pt"> 1,730,813 </span> </td> <td style="width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td> <span style="font-size: 10pt"> Brooks H. Pierce </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 39,146 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 354,271 </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> <span style="font-size: 10pt"> Marilyn Jentzen </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <!-- Field: Page; Sequence: 27; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 22 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Consists of the following unvested awards: </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (i) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> RSUs granted on May 11, 2021 to Mr. Weil in connection with his employment agreement, as modified on June 21, 2021, comprised of two tranches totaling 97,500 stock-price based RSUs (50,000 RSUs vesting at a stock price $17.50 per share and 47,500 RSUs vesting at a stock price of $20.00 per share) that have not yet vested. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 3%; text-align: justify"> </td> <td style="width: 4%; text-align: justify"> <span style="font-size: 10pt"> (ii) </span> </td> <td style="width: 93%; text-align: justify"> <span style="font-size: 10pt"> RSUs granted on February 14, 2023 to Mr. Weil and Mr. Pierce in the original amounts of 25,078 and 19,500, respectively, as to which one-third vested on each of December 29, 2023 and December 31, 2024 and one-third is scheduled to vest on December 31, 2025. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> (iii) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> RSUs granted as performance-based RSUs on February 14, 2023 to Mr. Weil and Mr. Pierce in the target amounts of 25,078 and 19,500, respectively, as to which vesting was conditioned on attainment of pre-established performance criteria for 2023. The performance criteria applicable to the RSUs was met at approximately 46.63%. The awards remain subject to a time-based vesting schedule (i.e., vesting in one installment on December 31, 2025). </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> (iv) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> RSUs granted on May 9, 2023 to Mr. Weil in connection with his employment agreement in the amount of 125,000 stock price based RSUs (four equal tranches conditioned on attainment of specified price targets ($15.00 per share, $17.50 per share, $20.00 per share and $22.50 share). The first stock price target has been met and the tranche was vested on May 9, 2023. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> (v) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> RSUs granted on March 8, 2024 to Mr. Weil and Mr. Pierce in the original amounts of 40,000 and 18,595, respectively, as to which one-third vested on December 31, 2024 and one-third is scheduled to vest on each of December 31, 2025 and December 31, 2026. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> (vi) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> RSUs granted as performance-based RSUs on March 8, 2024 to Mr. Weil and Mr. Pierce in the target amounts of 40,000 and 18,595, respectively, as to which vesting was conditioned on attainment of pre-established performance criteria for 2024. The performance criteria applicable to the RSUs was met in excess of the threshold level and the Compensation Committee exercised discretion to increase their amounts to 60% of their target awards. The awards remain subject to a time-based vesting schedule (i.e., vesting in one installment on December 31, 2026). </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (2) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The values shown were calculated by multiplying the number of shares subject to the awards by the closing price of the Company’s Common Stock on December 31, 2024 ($9.05). In the case of performance RSUs under the Equity Incentive Plan Awards Value column, the value shown was calculated based on target performance. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (3) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> All of the awards shown for Mr. Weil are held by an entity (Hydralex Holdings LLC) whose membership interests are <span style="background-color: white"> owned by trusts for the benefit of Mr. Weil’s children and other beneficiaries including Mr. Weil. The awards were transferred for estate planning purposes in May 2024. </span> </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (4) </span> </td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In addition to the awards reflected in the table (i.e., unvested RSUs as of December 31, 2024), the Named Executive Officers (or a transferee in Mr. Weil’s case) held the following vested (but unsettled) RSUs as of December 31, 2024: Mr. Weil, 1,665,204 RSUs; and Mr. Pierce, 212,054 RSUs. A portion of these RSUs settled in January 2025 (Mr. Weil, 55,182; Mr. Pierce, 37,054). The balance of vested RSUs are subject to settlement deferral during the employment of the award recipient. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The table also does not include certain tranches of performance-based RSUs approved under the terms of employment agreements with Mr. Weil and Mr. Pierce as to which the targets (and, accordingly, the accounting grant dates) were not established on or before December 31, 2024. Such RSUs comprise three tranches totaling 125,000 RSUs for Mr. Weil (subject to performance criteria for 2025, 2026 and 2027) and two tranches totaling 125,000 RSUs for Mr. Pierce (subject to performance criteria for 2025 and 2026). The targets for each tranche are anticipated to be set in February of the performance year for the tranche (e.g., February 2025 for the tranche relating to 2025 performance). </p> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <!-- Field: Page; Sequence: 28; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 23 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Pay Versus Performance </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Pursuant to Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information regarding “compensation actually paid”, as defined in Item 402(v), and certain financial performance of the Company. In accordance with SEC rules, the “compensation actually paid” amounts shown in the table below for each applicable year reflect certain adjustments to the values reported in the Summary Compensation Table of the proxy statement as described in the footnotes to the following table. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000015" name="ecd:PvpTableTextBlock"> <table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_zleECjSkEDV5" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Year </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48D_eecd--PeoTotalCompAmt_zUggemKNhXKk" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Summary Compensation Table Total for PEO <sup id="xdx_F5C_zycVOdXWvuqa"> (1) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_481_eecd--PeoActuallyPaidCompAmt_zgPfuoXygTA5" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Compensation Actually Paid to PEO <sup id="xdx_F5F_zfPV4pNqEbH6"> (2) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zTNb4yU0giIe" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Average Summary Compensation Table Total for Non-PEO NEOs <sup id="xdx_F5C_zRiFclyjs3h6"> (1) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_487_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zN5Seyhi599" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Average Compensation Actually Paid to Non-PEO NEOs <sup id="xdx_F5A_zfCC8b9NJ2c5"> (2) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48D_eecd--TotalShareholderRtnAmt_pp2d_zDegbxXrqcu6" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Value of Initial Fixed $100 Investment Based On: Total Shareholder Return <sup id="xdx_F53_zu5M7i8Q6WAe"> (3) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_48E_eus-gaap--NetIncomeLoss_pn5n6_zRhNlnAU8xn8" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Net Income (millions) <sup id="xdx_F50_zljXygGxcYf9"> (4) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_480_eecd--CoSelectedMeasureAmt_pn5n6_uUSD_zLAxHcTPr3rg" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Adjusted </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> EBITDA </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> (millions) <sup id="xdx_F54_zdCW38ncDyq4"> (4)(5) </sup> </b> </p> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> <span style="font-size: 10pt"> (a) </span> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (b) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (c) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (d) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (e) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (f) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (g) </span> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> <span style="font-size: 10pt"> (h) </span> </td> <td> </td> </tr> <tr id="xdx_41D_20240101__20241231_zB3EFodKtJw" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000016" name="ecd:PeoTotalCompAmt" unitRef="USD"> 2,667,525 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000017" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 1,716,384 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000018" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 1,458,728 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000019" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,226,700 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="2" format="ixt:numdotdecimal" id="Fact000020" name="ecd:TotalShareholderRtnAmt" unitRef="USD"> 69.83 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000021" name="us-gaap:NetIncomeLoss" scale="6" unitRef="USD"> 64.8 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000022" name="ecd:CoSelectedMeasureAmt" scale="6" unitRef="USD"> 100.1 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr id="xdx_417_20230101__20231231_zXDh92bJvwl1" style="vertical-align: bottom; background-color: White"> <td style="width: 7%; text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000023" name="ecd:PeoTotalCompAmt" unitRef="USD"> 4,514,234 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000024" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 2,893,424 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000025" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 2,035,415 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000026" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,436,436 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="2" format="ixt:numdotdecimal" id="Fact000027" name="ecd:TotalShareholderRtnAmt" unitRef="USD"> 76.23 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 10%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000028" name="us-gaap:NetIncomeLoss" scale="6" unitRef="USD"> 6.9 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 12%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000029" name="ecd:CoSelectedMeasureAmt" scale="6" unitRef="USD"> 99.2 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> </tr> <tr id="xdx_41E_20220101__20221231_zB18rAMKJ2Hd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000030" name="ecd:PeoTotalCompAmt" unitRef="USD"> 3,752,193 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000031" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 3,329,440 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000032" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 1,834,359 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000033" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,686,664 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="2" format="ixt:numdotdecimal" id="Fact000034" name="ecd:TotalShareholderRtnAmt" unitRef="USD"> 97.76 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000035" name="us-gaap:NetIncomeLoss" scale="6" unitRef="USD"> 21.2 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="-5" format="ixt:numdotdecimal" id="Fact000036" name="ecd:CoSelectedMeasureAmt" scale="6" unitRef="USD"> 99.5 </ix:nonFraction> </span> </td> <td> </td> </tr> </table> </ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="text-align: left; width: 0.25in"> <span style="font-size: 10pt"> <sup id="xdx_F02_zuepFAich9O4"> (1) </sup> </span> </td> <td style="text-align: justify"> <span id="xdx_F11_zxDZ1iHW44a2" style="font-size: 10pt"> <ix:footnote id="Footnote000037" xml:lang="en-US"> The dollar amounts reported in column (b) are the amounts of total compensation reported for Mr. Weil in the “Total” column of the Summary Compensation Table for each applicable year. Mr. Weil was our Principal Executive Officer (PEO) for all applicable years. The dollar amounts reported in column (d) represent the average of the amounts reported for our Named Executive Officers (NEOs), other than our PEO, in the “Total” column of the Summary Compensation Table in each applicable year. Our NEOs, other than our PEO, were as follows —for 2022, Brooks Pierce and Daniel Silvers; for 2023, Brooks Pierce, Carys Damon and Daniel Silvers; and for 2024, Brooks Pierce and Marilyn Jentzen. </ix:footnote> </span> </td> </tr> </table> <p style="display: none; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="display: none; vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="text-align: left; width: 0.25in"> <span style="font-size: 10pt"> <sup id="xdx_F01_zAvViKkkORL1"> (2) </sup> </span> </td> <td style="text-align: justify"> <span id="xdx_F18_z28636s9IMi3" style="font-size: 10pt"> <ix:footnote id="Footnote000038" xml:lang="en-US"> The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Mr. Weil, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the NEOs, other than our PEO, as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to determine the “compensation actually paid” amounts reported above for the PEO and the average paid to the other NEOs: </ix:footnote> </span> </td> </tr> </table> <p style="display: none; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"> <span style="font-size: 10pt"> <sup id="xdx_F08_zfU7iEv8Qk2b"> (3) </sup> </span> </td> <td style="text-align: justify"> <span id="xdx_F13_zNfQodwtaICl" style="font-size: 10pt"> <ix:footnote id="Footnote000039" xml:lang="en-US"> Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. </ix:footnote> </span> </td> </tr> </table> <p style="display: none; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="display: none; vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"> <span style="font-size: 10pt"> <sup id="xdx_F0C_zx9RIEiN3AMl"> (4) </sup> </span> </td> <td style="text-align: justify"> <span id="xdx_F1F_zV4FpCTyxZd4" style="font-size: 10pt"> <ix:footnote id="Footnote000040" xml:lang="en-US"> The amounts shown in the columns for net income and Adjusted EBITDA for 2022 and 2023 reflect the revised amounts reported in the financial statements of the Company contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 26, 2025. </ix:footnote> </span> </td> </tr> </table> <p style="display: none; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="display: none; vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="text-align: left; width: 0.25in"> <span style="font-size: 10pt"> <sup id="xdx_F0D_zFZdlEUm0mE1"> (5) </sup> </span> </td> <td style="text-align: justify"> <p style="margin-top: 0; margin-bottom: 0"> <span id="xdx_F12_zgAgNQ0yLv01" style="font-size: 10pt"> <ix:footnote id="Footnote000041" xml:lang="en-US"> Adjusted EBITDA, a non-GAAP financial measure, is defined as net income (loss) excluding depreciation and amortization, interest expense, interest income and income tax expense, and other additional exclusions and adjustments <i> . </i> Such additional excluded amounts include stock-based compensation U.S. GAAP charges where the associated liability is expected to be settled in stock, and changes in the value of earnout liabilities and income and expenditure in relation to legacy portions of the business (being those portions where trading no longer occurs) including closed defined benefit pension schemes. Additional adjustments are made for items considered outside the normal course of business, including (1) restructuring costs, which include charges attributable to employee severance, management changes, restructuring, dual running costs, costs related to facility closures and integration costs, (2) merger and acquisition costs, (3) gains or losses not in the ordinary course of business and (4) the costs of the restatement of previously issued financial statements. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the company to link compensation actually paid to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. </ix:footnote> </span> For a discussion of Adjusted EBITDA and a reconciliation of net income to Adjusted EBITDA for 2023 and 2024, see pages 53-55 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. For a reconciliation of net income to Adjusted EBITDA for 2022, <span style="background-color: white"> see pages 56 – 57 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 except for the following revised amounts: net income -- $21.2 million (reflects increase of $0.6 million); interest expense -- $25.2 million (reflects decrease of $0.1 million); and Adjusted EBITDA -- $99.5 million (reflects increase of $0.5 million) (the revisions to net income and interest expense for the 2022 fiscal year were reported in the Company’s Annual Report on Form 10-K for 2024). </span> </p> </td> </tr> </table> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000043" name="ecd:NamedExecutiveOfficersFnTextBlock"> <p id="xdx_89F_eecd--NamedExecutiveOfficersFnTextBlock_dU_zX3F7FgaSwWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> <sup> (1) </sup> </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The dollar amounts reported in column (b) are the amounts of total compensation reported for Mr. Weil in the “Total” column of the Summary Compensation Table for each applicable year. <span id="xdx_903_eecd--PeoName_c20220101__20221231_z4yfKzF2ykZg"> <span id="xdx_902_eecd--PeoName_c20230101__20231231_zhyyffjUtxXh"> <span id="xdx_903_eecd--PeoName_c20240101__20241231_zfGSvrD53PPl"> <ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000044" name="ecd:PeoName"> <ix:nonNumeric contextRef="From2023-01-012023-12-31" id="Fact000045" name="ecd:PeoName"> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000046" name="ecd:PeoName"> Mr. Weil </ix:nonNumeric> </ix:nonNumeric> </ix:nonNumeric> </span> </span> </span> was our Principal Executive Officer (PEO) for all applicable years. The dollar amounts reported in column (d) represent the average of the amounts reported for our Named Executive Officers (NEOs), other than our PEO, in the “Total” column of the Summary Compensation Table in each applicable year. Our NEOs, other than our PEO, were as follows —for 2022, Brooks Pierce and Daniel Silvers; for 2023, Brooks Pierce, Carys Damon and Daniel Silvers; and for 2024, Brooks Pierce and Marilyn Jentzen. </span> </td> </tr> </table> </ix:nonNumeric> <p id="xdx_8A7_zd2r9Si6xYCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> <sup> (2) </sup> </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Mr. Weil, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the NEOs, other than our PEO, as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to determine the “compensation actually paid” amounts reported above for the PEO and the average paid to the other NEOs: </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <sup> </sup> </p> <!-- Field: Page; Sequence: 29; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 24 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000048" name="ecd:AdjToPeoCompFnTextBlock"> <p id="xdx_897_eecd--AdjToPeoCompFnTextBlock_dU_z1tYNCLAkXhc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <sup> </sup> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Adjustments to Summary Compensation Total to Determine Compensation Actually Paid </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Year </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Amounts Reported under the Summary Compensation Table Total column </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Deduction for Amounts included in the prior column for “Stock Awards” <sup> (a) </sup> </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Inclusion of </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Equity Values <sup> (b) </sup> </b> </p> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Compensation Actually Paid </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 16%; text-align: justify"> <span style="font-size: 10pt"> PEO </span> </td> <td style="width: 2%"> </td> <td style="width: 10%; text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td style="width: 2%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--PeoTotalCompAmt_c20240101__20241231_zWUbRVS2Bd66" style="width: 14%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000049" name="ecd:PeoTotalCompAmt" unitRef="USD"> 2,667,525 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zNe743SO8xpl" style="width: 14%; text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000050" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 1,391,725 </ix:nonFraction> </span> </td> <td style="width: 1%"> ) </td> <td style="width: 2%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zJnnFz0MS6Oa" style="width: 14%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000051" name="ecd:AdjToCompAmt" unitRef="USD"> 440,584 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_983_eecd--PeoActuallyPaidCompAmt_c20240101__20241231_zpgqBqNGvfr7" style="width: 14%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000052" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 1,716,384 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_986_eecd--PeoTotalCompAmt_c20230101__20231231_zMzbP2QDwVig" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000053" name="ecd:PeoTotalCompAmt" unitRef="USD"> 4,514,234 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zxs0Rm8qwHq4" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000054" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 3,238,812 </ix:nonFraction> </span> </td> <td> <span style="font-size: 10pt"> ) </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zeL3btranP7k" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000055" name="ecd:AdjToCompAmt" unitRef="USD"> 1,618,002 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_980_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_zWKVx3iJ1BMl" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000056" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 2,893,424 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--PeoTotalCompAmt_c20220101__20221231_zJse5fbWIwog" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000057" name="ecd:PeoTotalCompAmt" unitRef="USD"> 3,752,193 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_988_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zoDasHZDdMNj" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000058" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 1,658,317 </ix:nonFraction> </span> </td> <td> <span style="font-size: 10pt"> ) </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zzspMZXOn0F4" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_ecd_PeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000059" name="ecd:AdjToCompAmt" unitRef="USD"> 1,235,564 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98A_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_zovZSuDcypT5" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000060" name="ecd:PeoActuallyPaidCompAmt" unitRef="USD"> 3,329,440 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"> <span style="font-size: 10pt"> Average for Other NEOs </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_z3QfIk2834lc" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000061" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 1,458,728 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zSw9e2zOrUa1" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000062" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 316,255 </ix:nonFraction> </span> </td> <td> ) </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zzTu1ory6NZ8" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000063" name="ecd:AdjToCompAmt" unitRef="USD"> 84,227 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_988_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zsKCglM7SK7" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-01to2024-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000064" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,226,700 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zD3UntQsUgt1" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000065" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 2,035,415 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zXNBzbCNL4ck" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000066" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 604,895 </ix:nonFraction> </span> </td> <td> <span style="font-size: 10pt"> ) </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_980_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zQlPnEmzIVj5" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000067" name="ecd:AdjToCompAmt" unitRef="USD"> 5,916 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zNwahBLJjww6" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000068" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,436,436 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_983_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_zBkvA27GaYof" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000069" name="ecd:NonPeoNeoAvgTotalCompAmt" unitRef="USD"> 1,834,359 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember_fKGEp_zIUmhi7T90H6" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_DeductionForAmountsIncludedInThePriorColumnForStockAwardsMember" decimals="0" format="ixt:numdotdecimal" id="Fact000070" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 649,630 </ix:nonFraction> </span> </td> <td> <span style="font-size: 10pt"> ) </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--InclusionOfEquityValuesMember_fKGIp_zTwnI0WQIKof" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_InclusionOfEquityValuesMember" decimals="0" format="ixt:numdotdecimal" id="Fact000071" name="ecd:AdjToCompAmt" unitRef="USD"> 501,935 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zQG1nqnvppMa" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31" decimals="0" format="ixt:numdotdecimal" id="Fact000072" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" unitRef="USD"> 1,686,664 </ix:nonFraction> </span> </td> <td> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"> <span id="xdx_F06_zVBKWW7cJIjh" style="font-size: 10pt"> (a) </span> </td> <td style="text-align: justify"> <span id="xdx_F1E_z1WaDhuKVJ8j" style="font-size: 10pt"> <ix:footnote id="Footnote000073" xml:lang="en-US"> Represents the grant date fair value of equity compensation included in the Summary Compensation Table “Total” column as “Stock Awards” for the applicable year for the PEO and the average for the other NEOs. </ix:footnote> </span> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td> </td> <td> <span id="xdx_F0E_zONVWSupOaEe" style="font-size: 10pt"> (b) </span> </td> <td style="text-align: justify"> <span id="xdx_F19_zPkha1Yl7zya" style="font-size: 10pt"> <ix:footnote id="Footnote000074" xml:lang="en-US"> The amounts reported in column (b) were computed as follows: </ix:footnote> </span> </td> </tr> </table> </ix:nonNumeric> <p id="xdx_8AE_zNQhddJLL9f6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000076" name="ecd:EquityValuationAssumptionDifferenceFnTextBlock"> <p id="xdx_89B_eecd--EquityValuationAssumptionDifferenceFnTextBlock_dU_zilQlizs9gQa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Components that comprise amounts shown under column “Inclusion of Equity Values” in the table above </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Year </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Year End Fair Value of Outstanding and Unvested Equity Awards Granted During the Year </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Fair Value as of Vesting Date of Equity Awards Granted and Vested During the Year </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Change in Fair Value from End of the Prior Year to the Vesting Date of Equity Awards Granted in Prior Years that Vested During the Year </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions During the Year </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Value of Dividends or other Earnings Paid on Stock not Otherwise Reflected in Fair Value or Total Compensation </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> Total – Inclusion of Equity Values </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 11%"> <span style="font-size: 10pt"> PEO </span> </td> <td style="width: 1%"> </td> <td style="width: 4%; text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zPe4QI6di176" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000077" name="ecd:AdjToCompAmt" unitRef="USD"> 458,536 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zXtyVrPwjIB" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000078" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 598,956 </ix:nonFraction> ) </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_986_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_ztjfdrGRGJ4a" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000079" name="ecd:AdjToCompAmt" unitRef="USD"> 686,289 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zwl5WqMJBCr9" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000080" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 105,285 </ix:nonFraction> ) </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98B_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zRnfPPoMPOV4" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0081"> — </span> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_z4rMkTyKRMK3" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0082"> — </span> </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zCW50fODxmIa" style="width: 9%; text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000083" name="ecd:AdjToCompAmt" unitRef="USD"> 440,584 </ix:nonFraction> </span> </td> <td style="width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zTfR8brIDEg9" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000084" name="ecd:AdjToCompAmt" unitRef="USD"> 998,523 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zXGRNvQyjFEi" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000085" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 589,137 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zdwPmMtu6UO" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000086" name="ecd:AdjToCompAmt" unitRef="USD"> 1,089,774 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zjouMuYcfiWl" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000087" name="ecd:AdjToCompAmt" unitRef="USD"> 118,842 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_z11fEpmtOfZ4" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0088"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zIPI0rzzJN56" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0089"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zi1yYxWQ2Tbf" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000090" name="ecd:AdjToCompAmt" unitRef="USD"> 1,618,002 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zGLOqY7zWpb2" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000091" name="ecd:AdjToCompAmt" unitRef="USD"> 530,392 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zUaPN4OmAts6" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000092" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 171,525 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zT6BcIVgkCuh" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000093" name="ecd:AdjToCompAmt" unitRef="USD"> 897,948 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_z1GiyOpcgdY" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000094" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 21,251 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98B_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zElygpf7scl1" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0095"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zpebvfRFKlpl" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0096"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zO9YK71U0GO2" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_PeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000097" name="ecd:AdjToCompAmt" unitRef="USD"> 1,235,564 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: white"> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> <span style="font-size: 10pt"> Average for </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2024 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zFruzdFS4i45" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000098" name="ecd:AdjToCompAmt" unitRef="USD"> 106,582 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zfgb5BJFMIZa" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000099" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 6,471 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_985_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zHK9Hv3J4hCg" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000100" name="ecd:AdjToCompAmt" unitRef="USD"> 28,046 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_981_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z98j7x5ixZ0f" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000101" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 43,930 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zzpcSdoHQXoc" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0102"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z8C4NtmsOCI4" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0103"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zj4NYTAi80G2" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2024-01-012024-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000104" name="ecd:AdjToCompAmt" unitRef="USD"> 84,227 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> <span style="font-size: 10pt"> Other NEOs </span> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2023 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zuASLzwJVJPl" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000105" name="ecd:AdjToCompAmt" unitRef="USD"> 120,019 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z6ZgL72F6Zue" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000106" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 178,546 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zaXk8T2wh9s1" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000107" name="ecd:AdjToCompAmt" unitRef="USD"> 160,910 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zvM9ZxMOzG47" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000108" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 96,467 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zbdJvOkP7BPa" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0109"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z3Oa34USs8b4" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0110"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zp8DRvYUmgFl" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2023-01-012023-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000111" name="ecd:AdjToCompAmt" unitRef="USD"> 5,916 </ix:nonFraction> </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td style="text-align: center"> <span style="font-size: 10pt"> 2022 </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zTonVF9WWCg" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_YearEndFairValueOfOutstandingAndUnvestedEquityAwardsGrantedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000112" name="ecd:AdjToCompAmt" unitRef="USD"> 334,304 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_981_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zhMGJ52PzTb9" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000113" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 26,721 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zbDCuUPBnC74" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000114" name="ecd:AdjToCompAmt" unitRef="USD"> 225,235 </ix:nonFraction> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zpbsfduaRb7f" style="text-align: right"> <span style="font-size: 10pt"> ( <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_ChangeInFairValueFromEndOfThePriorYearToTheVestingDateOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000115" name="ecd:AdjToCompAmt" sign="-" unitRef="USD"> 30,883 </ix:nonFraction> ) </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_982_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z6sujOofSIg2" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0116"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_989_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockNotOtherwiseReflectedInFairValueOrTotalCompensationMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zBHNv2zOxp4j" style="text-align: right"> <span style="font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0117"> — </span> </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td id="xdx_98E_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zTqtgnb5Qxsc" style="text-align: right"> <span style="font-size: 10pt"> <ix:nonFraction contextRef="From2022-01-012022-12-31_custom_TotalInclusionOfEquityValuesMember_ecd_NonPeoNeoMember" decimals="0" format="ixt:numdotdecimal" id="Fact000118" name="ecd:AdjToCompAmt" unitRef="USD"> 501,935 </ix:nonFraction> </span> </td> <td> </td> </tr> </table> </ix:nonNumeric> <p id="xdx_8A0_zuFjHVQ0oMA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <sup> </sup> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> <sup> (3) </sup> </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Cumulative TSR is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> <sup> (4) </sup> </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> The amounts shown in the columns for net income and Adjusted EBITDA for 2022 and 2023 reflect the revised amounts reported in the financial statements of the Company contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 26, 2025. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 30; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 25 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> <sup> (5) </sup> </span> </td> <td style="text-align: justify"> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-size: 10pt"> <span id="xdx_908_eecd--CoSelectedMeasureName_c20240101__20241231_znYKPJarJj9j"> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000119" name="ecd:CoSelectedMeasureName"> Adjusted EBITDA </ix:nonNumeric> </span> , a non-GAAP financial measure, is defined as net income (loss) excluding depreciation and amortization, interest expense, interest income and income tax expense, and other additional exclusions and adjustments <i> . </i> Such additional excluded amounts include stock-based compensation U.S. GAAP charges where the associated liability is expected to be settled in stock, and changes in the value of earnout liabilities and income and expenditure in relation to legacy portions of the business (being those portions where trading no longer occurs) including closed defined benefit pension schemes. Additional adjustments are made for items considered outside the normal course of business, including (1) restructuring costs, which include charges attributable to employee severance, management changes, restructuring, dual running costs, costs related to facility closures and integration costs, (2) merger and acquisition costs, (3) gains or losses not in the ordinary course of business and (4) the costs of the restatement of previously issued financial statements. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation programs, the Company has determined that Adjusted EBITDA is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the company to link compensation actually paid to the Company’s NEOs, for the most recently completed fiscal year, to Company performance. </span> <span style="font-size: 10pt"/> </p> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"> <span style="font-size: 10pt"> For a discussion of Adjusted EBITDA and a reconciliation of net income to Adjusted EBITDA for 2023 and 2024, see pages 53-55 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. For a reconciliation of net income to Adjusted EBITDA for 2022, <span style="background-color: white"> see pages 56 – 57 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 except for the following revised amounts: net income -- $21.2 million (reflects increase of $0.6 million); interest expense -- $25.2 million (reflects decrease of $0.1 million); and Adjusted EBITDA -- $99.5 million (reflects increase of $0.5 million) (the revisions to net income and interest expense for the 2022 fiscal year were reported in the Company’s Annual Report on Form 10-K for 2024). </span> </span> </p> </td> </tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000121" name="ecd:Additional402vDisclosureTextBlock"> <p id="xdx_890_eecd--Additional402vDisclosureTextBlock_dU_ziKeukeZLTC6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> Analysis of the Information Presented in the Pay versus Performance Table </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <i> </i> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company’s executive compensation program reflects a variable pay-for-performance philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance, all of those Company measures are not presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company’s performance measures with compensation that is actually paid (as computed in accordance with Item 402(v) of Regulation S-K) for a particular year. In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between information presented in the Pay versus Performance table. </p> </ix:nonNumeric> <p id="xdx_8A2_ztrZDElYgiM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000123" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"> <p id="xdx_89E_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zDjFNeURp1Sb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> <span style="text-decoration: underline"> Compensation Actually Paid and Cumulative TSR </span> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The following graph illustrates the amount of “compensation actually paid” (“CAP”) to Mr. Weil and the average amount of CAP to the Company’s NEOs as a group (excluding Mr. Weil) relative to the Company’s cumulative total shareholder return (TSR) over the three years presented in the table. The CAP for 2022 reflects bonuses under the STIP bonus program that were approved for performance (measured by Adjusted EBITDA) in excess of the target. The CAP for 2023 reflects sign-on equity awards granted as part of employment agreement extensions. The CAP for 2023 and 2024 reflects a decline in the Company’s stock price relative to the beginning of the three-year period. A significant portion of compensation is comprised of performance-based bonuses and equity grants, including, in Mr. Weil’s case, equity awards that are conditioned on the attainment of stock price targets. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <img alt="" src="formdef14a_002.jpg" style="width: 700px"/> </p> </ix:nonNumeric> <p id="xdx_8A6_z17OtLRgnevk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"/> <!-- Field: Page; Sequence: 31; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 26 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000125" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"> <p id="xdx_890_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zkg9Oi27kx74" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> <span style="text-decoration: underline"> Compensation Actually Paid and Net Income </span> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The amount of CAP to Mr. Weil and the average amount of CAP to the Company’s NEOs as a group (excluding Mr. Weil) is not aligned with the Company’s net income over the three years presented in the table. The Company has not used net income as a performance measure in the overall executive compensation program. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <img alt="" src="formdef14a_005.jpg" style="width: 700px"/> </p> </ix:nonNumeric> <p id="xdx_8AB_zTfA0FahkiBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000127" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock"> <p id="xdx_89F_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zEF0hgo9IGi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> <i> <span style="text-decoration: underline"> Compensation Actually Paid and Adjusted EBITDA </span> </i> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company utilizes Adjusted EBITDA when setting goals for the Company’s annual performance bonuses and for the performance-based RSUs that are awarded to the NEOs. Approximately 51% of the value of total compensation awarded for target level performance to the NEOs is in the form of performance-based bonuses and restricted stock units tied to Adjusted EBITDA. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <b> <img alt="" src="formdef14a_004.jpg" style="width: 700px"/> </b> </p> </ix:nonNumeric> <p id="xdx_8A2_zMUdyRY6SOm5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"/> <!-- Field: Page; Sequence: 32; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 27 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Director Compensation </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company’s non-employee director compensation program was as follows in 2024: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Annual Cash </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Retainer </b> </p> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Annual RSU </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Award </b> </p> </td> <td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"> Board Members </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 14%; text-align: right"> 50,000 </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 14%; text-align: right"> 100,000 </td> <td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Lead Independent Director Additional Retainer and Equity </td> <td> </td> <td style="text-align: left"> $ </td> <td style="text-align: right"> 10,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> $ </td> <td style="text-align: right"> 10,000 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Committee Chair Additional Retainer and Equity </td> <td> </td> <td style="text-align: left"> $ </td> <td style="text-align: right"> 10,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> $ </td> <td style="text-align: right"> 10,000 </td> <td style="text-align: left"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> With respect to the annual awards of RSUs for 2024, the number of RSUs granted was determined under the non-employee compensation policy (as revised in 2023) by dividing the award value (as shown in the table) by the formula price of $15.73 (in comparison to the closing price on the date of grant which was $9.17) which reflected the <i> highest of </i> (i) the twenty trading day average closing price of the immediately preceding year’s high closing price of our Common Stock, (ii) the twenty trading day average closing price of our Common Stock before the date of grant and (iii) 80% of the price at which the formula RSUs were granted for the immediately preceding year. The RSUs vest in four equal installments, one-quarter on the date of grant and the remaining three quarters on the first day of each calendar quarter (i.e., April 1, July 1 and October 1). Directors may elect whether or not they wish to defer settlement of vested RSUs. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The compensation paid to individuals who served as non-employee directors is shown below for 2024: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold"> Name </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Fees Earned or Paid in Cash ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Stock Awards (1) ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Option Awards ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Non-Equity Incentive Plan Compensation ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> All Other Compensation ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Total ($) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left"> Michael R. Chambrello </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> 60,000 </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> 64,117 </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> — </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> — </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> — </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right"> 124,117 </td> <td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Ira H. Raphaelson </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 60,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 64,117 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 124,117 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Desirée G. Rogers </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 50,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 58,294 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 108,294 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Steven M. Saferin </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 60,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 64,117 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 124,117 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Katja Tautscher </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 50,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 58,294 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 108,294 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> John M. Vandemore </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 60,000 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 64,117 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 124,117 </td> <td style="text-align: left"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/> <td style="width: 0.25in; text-align: left"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Represents annual grants of RSUs. The grant date fair value was computed in accordance with FASB ASC Topic 718, by multiplying the number of shares subject to the award by the closing price of the common stock on the grant date. For additional information, see our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As of December 31, 2024, the aggregate stock awards, consisting of RSUs, held by our non-employee directors were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold"> Name </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Total Number of </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> RSUs <sup> (1) </sup> </b> </p> </td> <td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 82%; text-align: left"> Michael R. Chambrello </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> 22,555 </td> <td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> Ira H. Raphaelson </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 42,716 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> Desirée G. Rogers </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 49,390 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> Steven M. Saferin </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 54,096 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Katja Tautscher </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 26,896 </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> John M. Vandemore </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 63,099 </td> <td style="text-align: left"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> All outstanding RSUs held by the directors were vested as of fiscal year-end. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 33; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 28 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Securities Authorized for Issuance under Equity Compensation Plans </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As of December 31, 2024, we had the following equity compensation plans, under which the indicated number of securities were issuable upon the exercise of outstanding awards, and the indicated number of securities remained available for future issuance: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold"> Plan Category </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> <span style="font-size: 10pt"> <b> Number of <br/> securities to be <br/> issued upon <br/> exercise of <br/> outstanding <br/> options, warrants <br/> and rights <sup> (1) </sup> </b> </span> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> <span style="font-size: 10pt"> <b> Weighted-average <br/> exercise price of <br/> outstanding <br/> options, <br/> warrants <br/> and rights <sup> (1) </sup> </b> </span> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> <span style="font-size: 10pt"> <b> Number of <br/> securities <br/> remaining <br/> available for <br/> future issuance <br/> under equity <br/> compensation plans <br/> (excluding <br/> securities <br/> reflected in <br/> column (a)) <sup> (2) </sup> </b> </span> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"> (a) </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> (b) </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> (c) </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left"> <span style="font-size: 10pt"> Equity compensation plans approved by security holders <sup> (2) </sup> </span> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> 3,679,487 </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> (1 </td> <td style="width: 1%; text-align: left"> ) </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> 3,024,501 </td> <td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Equity compensation plans not approved by security holders </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> — </td> <td style="text-align: left"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Reflects outstanding awards of RSUs, which have no exercise price. Includes an aggregate of 250,000 performance-based RSUs that were reserved for awards approved during 2023 (subject to performance criteria to be established for 2025-2027) but as to which the performance criteria (and, accordingly, the accounting grant dates) were not established on or before December 31, 2024. Excludes purchase rights accruing under the Employee Stock Purchase Plan. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (2) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Equity compensation plans approved by security holders consist of the 2016 Long-Term Incentive Plan, the Second Long-Term Incentive Plan, the 2018 Omnibus Incentive Plan, the 2021 Omnibus Incentive Plan, the 2023 Omnibus Incentive Plan and the Employee Stock Purchase Plan. The number of shares remaining available for issuance was as follows as of December 31, 2024: 2,564,500 shares under the 2023 Omnibus Incentive Plan (which includes shares rolled over from the 2021 Omnibus Incentive Plan) and 460,001 under the Employee Stock Purchase Plan (which includes approximately 125,000 shares subject to purchase rights that are accruing under the Employee Stock Purchase Plan). </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <!-- Field: Page; Sequence: 34; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 29 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_004"/> SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The following table sets forth information known as of March 28, 2025, the Record Date, regarding the beneficial ownership of our common stock by: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> each person who is known to be the beneficial owner of more than 5% of the outstanding shares of our common stock; and </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> each of our directors and named executive officers (named in our summary compensation table), as well as a group total for all of our current directors and executive officers (including those not named in our summary compensation table). </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if the person possesses sole or shared voting or investment power over that security, including options, warrants or RSUs that are currently exercisable or convertible or exercisable or convertible within 60 days of the date as of which information is provided. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The beneficial ownership of our common stock is based on 26,904,832 shares of common stock outstanding as of the Record Date. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Unless otherwise indicated, we believe that all persons named in the table below have sole voting and investment power with respect to all shares of common stock beneficially owned by them. In addition, unless otherwise indicated, the address for each person named below is c/o Inspired Entertainment, Inc., 250 West 57th Street, Suite 415, New York, NY 10107. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold"> Name of Beneficial Owner </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> Number of Shares of <br/> Common Stock (1) </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Percent of </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> Class </b> </p> </td> <td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"> MIHI LLC </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> 3,023,750 </td> <td style="width: 1%; text-align: left"> (2) </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 14%; text-align: right"> 11.2 </td> <td style="width: 1%; text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Samjo Management, LLC </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 2,598,922 </td> <td style="text-align: left"> (3) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 9.7 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> David L. Kanen / Kanen Wealth Management, LLC </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 1,825,258 </td> <td style="text-align: left"> (4) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 6.8 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Cannell Capital LLC </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 1,749,364 </td> <td style="text-align: left"> (5) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 6.5 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> 683 Capital Management, LLC </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 1,700,000 </td> <td style="text-align: left"> (6) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 6.3 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> BlackRock, Inc. </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 1,533,602 </td> <td style="text-align: left"> (7) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 5.7 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> A. Lorne Weil </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 2,954,755 </td> <td style="text-align: left"> (8) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 10.4 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Michael R. Chambrello </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 70,774 </td> <td style="text-align: left"> (9) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Ira H. Raphaelson </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 71,237 </td> <td style="text-align: left"> (10) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Desiree G. Rogers </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 53,364 </td> <td style="text-align: left"> (11) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Steven M. Saferin </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 59,267 </td> <td style="text-align: left"> (12) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Katja Tautscher </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 30,870 </td> <td style="text-align: left"> (13) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> John M. Vandemore </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 68,470 </td> <td style="text-align: left"> (14) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> Brooks H. Pierce </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 477,862 </td> <td style="text-align: left"> (15) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 1.8 </td> <td style="text-align: left"> % </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> Marilyn Jentzen </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 0 </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> - </td> <td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> All current directors and executive officers as a group (10 persons) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 3,786,599 </td> <td style="text-align: left"> (16) </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> 13.1 </td> <td style="text-align: left"> % </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.35in; text-align: justify"> <span style="font-size: 10pt"> * </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Less than 1 percent </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Derivative securities such as options, warrants and RSUs that are exercisable or convertible into shares of common stock within 60 days of the date as of which information is provided in this table are deemed to be beneficially owned and outstanding for purposes of computing the ownership of the person holding such securities but are not deemed to be outstanding for purposes of computing the ownership of any other person. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.35in; text-align: justify"> <span style="font-size: 10pt"> (2) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G filed on January 3, 2017, Macquarie Group Limited is the ultimate indirect parent of MIHI LLC and may be deemed to beneficially own or otherwise exercise dispositive powers with respect to the shares held by MIHI LLC. The business address listed in the Schedule 13G for Macquarie Group Limited is 50 Martin Place Sydney, New South Wales, Australia, and the business address listed in the Schedule 13G for MIHI LLC is 125 West 55th Street, New York, NY 10019. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Page; Sequence: 35; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 30 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.35in"> <span style="font-size: 10pt"> (3) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G/A filed on November 13, 2024, Samjo Management, LLC and Andrew N. Wiener, the Managing Member of Samjo Management, LLC, have shared voting power with respect to 1,222,000 shares and shared dispositive power with respect to 2,598,922 shares. The business address listed for such persons in the Schedule 13G/A is 880 Third Avenue, 16th Floor, New York, NY 10022. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (4) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G filed on February 5, 2025, Kanen Wealth Management, LLC and David Kanen, the Managing Member of Kanen Wealth Management, LLC, have shared voting and dispositive power with respect to 1,699,408 shares and David Kanen has sole voting and dispositive power with respect to 125,850 shares. The business address listed for such persons in the Schedule 13G is 6810 Lyons Technology Circle, Suite 160, Coconut Creek, Florida 33073. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (5) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G/A filed on February 13, 2025, Cannell Capital LLC and J. Carlo Cannell, the Managing Member of Cannell Capital LLC, have shared voting and dispositive power with respect to the shares. The business address listed for such persons in the Schedule 13G/A is 245 Meriwether Circle, Alta, WY 83414. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (6) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G/A filed on February 14, 2025, 683 Capital Management, LLC, 683 Capital Partners, LP and Ari Zweiman, the Managing Member of 683 Capital Management, LLC, have shared voting dispositive power with respect to the shares. The business address listed for such persons in the Schedule 13G/A is 3 Columbus Circle, Suite 2205, New York, NY 10019. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (7) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> According to a Schedule 13G/A filed on January 29, 2024, BlackRock, Inc. has sole voting power with respect to 1,520,260 shares and sole dispositive power with respect to 1,533,602 shares. The business address listed in the Schedule 13G/A is 55 East 52nd Street, New York, NY 10055. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (8) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 30,220 shares and 1,610,022 shares subject to vested RSUs held by Hydralex Holdings LLC and 493,015 shares held by Angele Delaware Investments LLC (collectively, the “LLCs”). The LLCs are owned by trusts for the benefit of Mr. Weil’s children and other beneficiaries, including Mr. Weil. Also includes 522,771 shares held by trusts for the benefit of Mr. Weil’s children. According to a Schedule 13D/A filed on July 2, 2024, Carly Weil (who is Mr. Weil’s niece), holds various roles with respect to the LLCs and the trusts and may be deemed to beneficially own the shares held by the LLCs and the trusts. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (9) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 10,070 shares held by the Denise M. Chambrello Revocable Trust, as to which Mr. Chambrello and his spouse are co-trustees. Also includes 22,555 shares subject to vested RSUs and 2,186 RSUs scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (10) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 42,716 shares subject to vested RSUs and 2,186 scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (11) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 49,390 shares subject to vested RSUs and 1,987 scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (12) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 56,281 shares subject to vested RSUs and 2,186 scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (13) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 28,883 shares subject to vested RSUs and 1,987 scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (14) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 65,284 shares subject to vested RSUs and 2,186 scheduled to vest within 60 days. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (15) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes 175,000 shares subject to vested RSUs. </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> <span style="font-size: 10pt"> (16) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Includes an aggregate of 2,050,131 shares subject to vested RSUs and 12,718 shares subject to RSUs that are scheduled to vest within 60 days. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> </b> </p> <!-- Field: Page; Sequence: 36; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 31 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_005"/> CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Nicholas Weil, the son of A. Lorne Weil, our Executive Chairman, is employed by a subsidiary of the Company. For 2024, he was paid a base salary of $150,000 and he was awarded a bonus under the Company’s STIP in the amount of $21,495. He received 2,383 RSUs under the Company’s equity award program for 2024. Effective April 1, 2025, Nicholas Weil’s annual base salary rate was increased to $180,000. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Richard Weil, the brother of A. Lorne Weil, provides consulting services to the Company under an agreement dated December 31, 2021, as amended. For 2024, Richard Weil received an aggregate of $150,000 in consulting fees and $34,000 in reimbursement for out-of-pocket expenses. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> David Kesterson, the stepson of Steven Saferin, a member of our Board and Chairman of the Compensation Committee, is employed by a subsidiary of the Company. For 2024, he was paid a base salary of $100,000 and he was awarded a bonus under the Company’s STIP in the amount of $7,687. He received 635 RSUs under the Company’s equity award program for 2024. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> From February 2023 to November 2023, Marilyn Jentzen provided consulting services to the Company in the areas of finance and accounting under an agreement between the Company and HighPoint Associates, LLC, a consulting firm, for which the firm invoiced an aggregate of $327,800 in consulting fees. In addition, the Company incurred costs during 2023 and 2024 under the “replacement fee” provisions of the consulting agreement in connection with the Company’s employment of Ms. Jentzen, in amounts equal to 15% of her compensation for the first twelve months of her employment. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Policies and Procedures for Related Person Transactions </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our Audit Committee must review and approve any related person transaction we propose to enter into. Our Audit Committee charter details the policies and procedures relating to transactions that may present actual, potential or perceived conflicts of interest and may raise questions as to whether such transactions are consistent with the best interest of the company and our stockholders. A summary of such policies and procedures is as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Any potential related party transaction that is brought to the Audit Committee’s attention will be analyzed by the Audit Committee, in consultation with outside counsel or members of management, as appropriate, to determine whether the transaction or relationship does, in fact, constitute a related party transaction. At each of its meetings, the Audit Committee will be provided with the details of each new, existing or proposed related party transaction, including the terms of the transaction, the business purpose of the transaction, and the benefits to us and to the relevant related party. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In determining whether to approve a related party transaction, the Audit Committee must consider, among other factors, the following factors to the extent relevant: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> whether the terms of the transaction are fair to us and on the same basis as would apply if the transaction did not involve a related party; </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> whether there are business reasons for us to enter into the transaction; </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> whether the transaction would impair the independence of an outside director; and </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> whether the transaction would present an improper conflict of interest for any director or executive officer. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Any member of the Audit Committee who has an interest in the transaction under discussion must abstain from voting on the approval of the transaction, but may, if so requested by the Chairman of the Audit Committee, participate in some or all of the Compensation Committee’s discussions of the transaction. Upon completion of its review of the transaction, the Audit Committee may determine to permit or to prohibit the transaction. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 37; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 32 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_006"/> PROPOSALS TO BE VOTED ON: </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> PROPOSAL NUMBER ONE—ELECTION OF DIRECTORS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Director Nominees </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Board proposes the election of the following seven individuals to serve on the Board until the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: A. Lorne Weil, Michael R. Chambrello, Ira H. Raphaelson, Desiree G. Rogers, Steven M. Saferin, Katja Tautscher and John M. Vandemore. Each of these individuals currently serves on the Company’s Board. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Pursuant to a stockholders agreement dated December 23, 2016 by and among the Company, the sponsors of the Company’s initial public offering and certain other parties, Mr. Weil is the designated director of the Hydra Sponsor; and Messrs. Chambrello and Raphaelson are the joint designees of the Macquarie Sponsor and Hydra Sponsor. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Brief statements as to each nominee’s background and a statement as to why the Board considers such nominee to be qualified and recommends such nominee for election are set forth above under the heading “Directors, Executive Officers and Corporate Governance.” Each nominee has advised us that he or she is willing to be named as a director nominee and to serve as a director if elected. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Vote Required for Approval </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Assuming there is a quorum, the directors will be elected by a plurality of the votes cast. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Recommendation of the Board </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ELECTION OF THE SEVEN DIRECTOR NOMINEES TO SERVE ON THE BOARD UNTIL THE 2026 ANNUAL MEETING OF STOCKHOLDERS OR UNTIL THEIR RESPECTIVE SUCCESSORS ARE DULY ELECTED AND QUALIFIED. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 38; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 33 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_007"/> PROPOSAL NUMBER TWO—RATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITOR </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our Audit Committee charter provides that the Audit Committee is responsible for appointing the Company’s independent auditor. The Audit Committee has appointed CBIZ CPAs P.C. (“CBIZ”) to serve as the Company’s independent auditor for our fiscal year ending December 31, 2025 and recommends that the Company’s stockholders ratify the appointment of CBIZ. Marcum LLP (“Marcum”) served as the Company’s independent auditor from 2016 except for the period from March 17, 2023 to November 22, 2023, when KPMG LLP (“KPMG”) performed such role. On November 1, 2024, CBIZ acquired the attest business of Marcum. As a result of this transaction, on April 11, 2025, Marcum resigned as auditor of the Company, and with the approval of the Audit Committee, CBIZ was engaged as the Company’s new independent registered public accounting firm. Neither CBIZ nor Marcum is expected to have a representative attend the Annual Meeting. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> If this proposal is not approved at the Annual Meeting, our Audit Committee will reconsider the selection of CBIZ but may determine that continued retention is in our Company’s and our stockholders’ best interests. Even if the appointment is ratified, the Audit Committee, in its discretion, may select a different independent registered public accounting firm at any time if it determines a change would be in our Company’s and our stockholders’ best interests. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Fees Paid to Independent Registered Public Accounting Firm </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Marcum audited our financial statements for the fiscal years ended December 31, 2024 and December 31, 2023. The aggregate fees billed to us for services provided by Marcum were as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Twelve Months Ended <br/> December 31, 2024 </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"> <span style="font-size: 10pt"> <b> Twelve Months Ended <br/> December 31, 2023 </b> </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%"> <span style="font-size: 10pt"> Audit fees (1) </span> </td> <td style="width: 2%"> </td> <td style="width: 1%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 14%; text-align: right"> <span style="font-size: 10pt"> 5,127,340 </span> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 2%"> <span style="font-size: 10pt"> $ </span> </td> <td style="width: 14%; text-align: right"> <span style="font-size: 10pt"> 4,284,295 </span> </td> <td style="width: 1%"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> <span style="font-size: 10pt"> Audit-related fees </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> Tax fees </span> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> <span style="font-size: 10pt"> All other fees (2) </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> <span style="font-size: 10pt"> 427,986 </span> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right"> <span style="font-size: 10pt"> — </span> </td> <td style="padding-bottom: 1.5pt"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> <span style="font-size: 10pt"> Total </span> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 5,555,326 </span> </td> <td> </td> <td> </td> <td> <span style="font-size: 10pt"> $ </span> </td> <td style="text-align: right"> <span style="font-size: 10pt"> 4,284,295 </span> </td> <td> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (1) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> Audit fees include (i) fees associated with the audits of our consolidated financial statements; (ii) reviews of our interim quarterly consolidated financial statements and (iii) comfort letters, consents and other items related to SEC matters. The amounts shown for fiscal 2023 include fees billed in connection with the restated financial statements included in the Company’s 2022 Annual Report on Form 10-K/A which was filed in February 2024. The fees shown for 2023 do not include $1,501,784 for services rendered by KPMG, which served as our principal accountant for a portion of fiscal 2023 (March to November). </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"> <span style="font-size: 10pt"> (2) </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> These fees reflect costs, including Marcum’s outside counsel costs, associated with responding to the SEC’s subpoena (issued in March 2024) <span style="background-color: white"> seeking documents concerning, among other things, the Company’s restated financial statements filed with the SEC in February 2024. The SEC staff notified the Company in January 2025 that it had concluded its investigation. </span> </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Pre-Approval Policy </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our Audit Committee has pre-approved all auditing services and permitted non-audit services to be performed for us by our auditors, including the fees and terms thereof. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 39; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 34 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Change in Independent Registered Public Accounting Firm </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As disclosed in our Current Report on Form 8-K filed with the SEC on March 23, 2023, on March 17, 2023, the Company dismissed Marcum as the Company’s registered public accounting firm effective as of that date and approved the engagement of KPMG as our independent registered public accounting firm for the fiscal year ending December 31, 2023. These decisions were approved by the Audit Committee. The audit reports of Marcum on the Company’s financial statements as of and for the years ended December 31, 2022 and 2021 contained no adverse opinion or disclaimer of opinion nor were any such reports qualified or modified as to uncertainty, audit scope or accounting principle. The audit report of Marcum on the effectiveness of internal control over financial reporting as December 31, 2022 indicates that the company did not maintain effective internal control over financial reporting as at December 31, 2022 and 2021 because of the effect of material weaknesses as described below. During the fiscal years ended December 31, 2022 and 2021 and through March 17, 2023, there were no (i) disagreements with Marcum (as defined in Regulation S-K, Item 304(a)(1)(iv) and the related instructions to this item); or (ii) “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except that Marcum advised the Company that certain material weaknesses existed. During the fiscal years ended December 31, 2022 and 2021, and through March 18, 2023, the Company had not consulted KPMG regarding (i) application of accounting principles to any specified transaction, either completed or proposed, (ii) the type of audit opinion that might be rendered on the Company’s financial statements, or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)) of Regulation S-K or a reportable event (as defined in Item 304(a)(1)(v) of Regulation 8-K). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As disclosed in our Current Report on Form 8-K filed with the SEC on November 29, 2023, on November 22, 2023, KPMG was dismissed as the Company’s registered public accounting firm. KPMG had not issued any audit reports on the consolidated financial statements of the Company, and therefore, none exist that contain any adverse opinion or disclaimer of opinion, nor were any qualified or modified as to uncertainty, audit scope, or accounting principles. As reported in a Form 8-K filing dated November 8, 2023, in connection with the preparation of the consolidated financial statements for the quarterly period ended September 30, 2023, the Company, in consultation with KPMG, identified certain accounting errors relating to the compliance with U.S. GAAP in connection with the Company’s accounting policies for capitalizing software development costs, which materially impacted the fairness and reliability of previously issued consolidated financial statements. During the interim period from March 17, 2023 through November 22, 2023, the Company had no (1) disagreements with KPMG (as defined in Regulation S-K, Item 304(a)(1)(iv) and the related instructions to this item), or (2) “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except that KPMG advised the Company that: (i) internal controls necessary for the Company to develop reliable financial statements did not exist, (ii) the firm needed to substantially expand the scope of its audit due to information coming to its attention that if further investigated may materially impact the fairness or reliability of previously issued financial statements or to be issued covering the fiscal period subsequent to the date of the 2022 financial statements, (iii) due to the accountant’s dismissal, the firm did not so expand the scope of its audit or conduct such further investigation, and (iv) due to the accountant’s dismissal, the issue has not been resolved to the accountant’s satisfaction prior to its dismissal. On November 22, 2023, the Audit Committee also approved the decision to re-engage Marcum as the Company’s registered public accounting firm for the fiscal year ending December 31, 2023. During the two years ended December 31, 2022 and the interim period from January 1, 2023 through November 22, 2023, neither the Company nor anyone on the Company’s behalf consulted Marcum regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on financial statements; and as such neither a written report nor oral advice was provided to the Company that Marcum concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial issue; or (ii) any matter that was either the subject of a disagreement (as defined in Regulation S-K, Item 304(a)(1)(iv) and the related instructions to this item) or a “reportable event” (as defined in Regulation S-K, Item 304(a)(1)(v)). </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> As disclosed in our Current Report on Form 8-K filed with the SEC on April 17, 2025, on November 1, 2024, CBIZ acquired the attest business of Marcum. As a result of this transaction, on April 11, 2025, Marcum resigned as auditor of the Company, and with the approval of the Audit Committee, CBIZ was engaged as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025. The reports of Marcum regarding the Company’s financial statements for the fiscal years ended December 31, 2024 and 2023, did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. During the fiscal years ended December 31, 2024 and 2023, and through April 11, 2025, the date of Marcum’s resignation, there were (a) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) with Marcum on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Marcum, would have caused Marcum to make reference to such disagreement in its report and (b) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions). During the fiscal years ended December 31, 2024 and 2023, and through April 11, 2025, neither the Company nor anyone on the Company’s behalf consulted with CBIZ regarding (i) the application of accounting principles to a specific completed or contemplated transaction or regarding the type of audit opinions that might be rendered by CBIZ on the Company’s financial statements, and CBIZ did not provide any written or oral advice that was an important factor considered by the Company in reaching a decision as to any such accounting, auditing, or financial reporting issue or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions), as that term is described in Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Vote Required for Approval </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Assuming there is a quorum, this proposal will be approved if the majority of the votes cast in respect of such proposal by the stockholders present in person or represented by proxy are “for” votes. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Recommendation of the Board </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” RATIFICATION OF THE APPOINTMENT OF CBIZ CPAs P.C. AS THE INDEPENDENT AUDITOR OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025. </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 40; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 35 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> <span id="a_008"/> OTHER MATTERS </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> The Company knows of no other matters to be submitted to the stockholders at the Annual Meeting. If any other matters properly come before the stockholders at the Annual Meeting, it is the intention of the persons named on the proxy card to vote the shares represented by them on such matters according to their best judgment. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Stockholder Proposals </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Stockholders may present proper proposals for inclusion in our proxy statement and for consideration at next year’s annual meeting of stockholders by submitting their proposals in writing to our Secretary in a timely manner. For a stockholder proposal to be considered for inclusion in our proxy statement for our 2026 annual meeting of stockholders, our Secretary must receive the written proposal at our principal executive offices not later than December 30, 2025. In addition, stockholder proposals must comply with the requirements of Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. Stockholder proposals should be addressed to Inspired Entertainment, Inc., 250 West 57th Street, Suite 415, New York, New York 10107, Attention: Corporate Secretary. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Our bylaws also provide notice procedures for stockholders to nominate a person as a director and to propose business to be considered by stockholders at a meeting. In addition to other applicable requirements, stockholders wishing to nominate a candidate for director or to propose other business at the 2026 annual meeting of stockholders must ensure written notice is received by our Secretary at Inspired Entertainment, Inc., 250 West 57th Street, Suite 415, New York, New York 10107, not less than 90 or more than 120 days prior to the one-year anniversary of the date of the preceding year’s annual meeting of stockholders (between January 27, 2026 and February 26, 2026). However, if the date of the 2026 annual meeting of stockholders is advanced more than 45 days prior to, or delayed by more than 45 days after, the anniversary of the preceding year’s annual meeting of stockholders, then, to be timely, notice by the stockholder must be delivered not earlier than the 120 <sup> th </sup> day prior to such annual meeting of stockholders or later than the close of business on the later of (i) the 90th day prior to such annual meeting of stockholders or (ii) the 10th day following the day on which public announcement of the date of such meeting is first made. The public announcement of an adjournment of an annual meeting will not commence a new time period for the giving of a stockholder’s notice as described in this section. The notice must include all of the information required by the Company’s Bylaws. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> To be in proper written form, a stockholder’s notice to the Corporate Secretary with respect to any business (other than nominations) must set forth as to each such matter such stockholder proposes to bring before the annual meeting (a) a brief description of the matter desired to be brought before the annual meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event such business includes a proposal to amend our bylaws, the language of the proposed amendment) and the reasons for conducting such business at the annual meeting, (b) the name and address of the stockholder of record and the name and address of the beneficial owner, if any, on whose behalf the proposal is made, (c) the class or series and number of shares of our capital stock that are owned beneficially and of record by such stockholder and by the beneficial owner, if any, on whose behalf the proposal is made, (d) a description of all arrangements or understandings between such stockholder and the beneficial owner, if any, on whose behalf the proposal is made, and any other person or persons (including their names) in connection with the proposal of such business by such stockholder, (e) any material interest of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made in such business and (f) a representation that such stockholder intends to appear in person or by proxy at the annual meeting to bring such business before the meeting. The foregoing notice requirements will be deemed satisfied by a stockholder as to any proposal (other than nominations) if the stockholder has notified us of such stockholder’s intention to present such proposal at an annual meeting in compliance with Rule 14a-8 (or any successor thereof) under the Exchange Act and such stockholder has complied with the requirements of such rule for inclusion of such proposal in a proxy statement prepared by us to solicit proxies for such annual meeting. Notwithstanding the foregoing provisions of this section, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting to present the proposed business, such proposed business will not be transacted, notwithstanding that proxies in respect of such matter may have been received by the Company. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 41; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 36 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> To be in proper written form, a stockholder’s notice to the Corporate Secretary to nominate directors must set forth (i) as to each person whom the stockholder proposes to nominate for election as a director (A) the name, age, business address and residence address of the person, (B) the principal occupation or employment of the person, (C) the class or series and number of shares of capital stock of the Company that are owned beneficially or of record by the person and (D) any other information relating to the person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder; and (ii) as to the stockholder giving the notice (A) the name and record address of such stockholder and the name and address of the beneficial owner, if any, on whose behalf the nomination is made, (B) the class or series and number of shares of capital stock of the Company that are owned beneficially and of record by such stockholder and the beneficial owner, if any, on whose behalf the nomination is made, (C) a description of all arrangements or understandings relating to the nomination to be made by such stockholder among such stockholder, the beneficial owner, if any, on whose behalf the nomination is made, each proposed nominee and any other person or persons (including their names), (D) a representation that such stockholder intends to appear in person or by proxy at the meeting to nominate the persons named in its notice and (E) any other information relating to such stockholder and the beneficial owner, if any, on whose behalf the nomination is made that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a director if elected. Notwithstanding the foregoing provisions of this section, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual meeting to present the nomination, such nomination will be disregarded, notwithstanding that proxies in respect of such nomination may have been received by the Company. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In addition to the requirements described above, a stockholder must also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the foregoing matters. We may refuse to acknowledge any stockholder proposal not made in compliance with the foregoing procedures. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> In addition to satisfying the advance notice requirements under the Company’s Bylaws as described above, to comply with the SEC’s universal proxy rules, a person who intends to solicit proxies in support of director nominees other than the Company’s nominees must provide notice to the Company that sets forth the information required by SEC Rule 14a-9(b) under the Exchange Act. Such notice must be received no later than 60 calendar days prior to the anniversary of the previous year’s annual meeting. For any such director nominee to be included on our proxy card for the 2026 annual meeting of stockholders, the Company’s Secretary must receive notice under SEC Rule 14a-19 no later than March 7, 2026. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Householding Information </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> Unless we have received contrary instructions, we may send a single copy of our proxy materials to any household at which two or more stockholders reside if we believe the stockholders are members of the same family. This process, known as “householding,” reduces the volume of duplicate information received at any one household and helps to reduce our expenses. If you prefer to receive multiple sets of our proxy materials at the same address this year or in future years; or, if you share an address with another stockholder and would like to receive only a single set of our proxy materials, please request a change in your delivery preferences as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; text-align: justify"> </td> <td style="width: 0.25in; text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> If you are a record holder, you should contact us at our offices at Inspired Entertainment, Inc., 250 West 57th Street, Suite 415, New York, New York 10107, Attn: Corporate Secretary; or </span> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> </tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> ● </span> </td> <td style="text-align: justify"> <span style="font-size: 10pt"> If you are a beneficial owner, you should contact the bank, broker or other nominee that holds your shares. </span> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> <b> Where You Can Find More Information </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> We file annual and quarterly reports and other reports and information with the SEC. These reports and other information can be accessed over the Internet free of charge at the SEC’s website at www.sec.gov or at our website at www.inseinc.com. Our website also contains our Code of Ethics and our Board committee charters. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> If you have questions about this proxy statement or require assistance voting your shares, please contact us by telephone or in writing: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> Corporate Secretary </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> Inspired Entertainment, Inc. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> 250 West 57th Street, Suite 415 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> New York, New York 10107 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> Tel: (646) 565-3861 </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <!-- Field: Page; Sequence: 42; Value: 1 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 33%"> </td> <td style="width: 34%; text-align: center"> <!-- Field: Sequence; Type: Arabic; Name: PageNo --> 37 <!-- Field: /Sequence --> </td> <td style="width: 33%; text-align: right"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <b> FORM OF PROXY CARD (WHITE) </b> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <img alt="" src="proxy_001.jpg"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"/> <!-- Field: Page; Sequence: 43 --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 100%"> </td> </tr> </table> </div> <div style="break-before: page; margin-top: 6pt"> <p style="margin: 0pt"> </p> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <img alt="" src="proxy_002.jpg"/> </p> <!-- Field: Page; Sequence: 44; Options: Last --> <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"> <tr style="vertical-align: top; text-align: left"> <td style="width: 100%"> </td> </tr> </table> </div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <!-- Field: Set; Name: xdx; ID: xdx_088_labels --> <!-- eJwdzLEOgkAMgOHdxHdobjaU6Mams8MNbMShd1eVWCkpFw7fXmD//t9dU+pzrwMJ3CmwTO7k3jmPDWIppVqCSaX2wnNdX9BUGGVj7nhwHFPj57GlINzykm+i8bPmnn4wT+DZnmpfGiJDtyPYFOzssQ7+OCopiQ== --> <!-- Field: Set; Name: xdx; ID: xdx_08B_extensions --> <!-- 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 --> <noscript> <img src="https://www.sec.gov/akam/13/pixel_81508ea?a=dD1kZjYwOGQxMzllNjMyNGJkMWFlYzVmMzhlYWJlZTFlYTZjMzQ5OTdlJmpzPW9mZg==" style="visibility: hidden; position: absolute; left: -999px; top: -999px;"/> </noscript> </body> </html> </div> </div> <!---------------------------------------> <!----------- 3rd column ----------------> <!----------- RIGHT MENU ----------------> <section class="col-md-3 col-sm-3 col-lg-3 section toc" id="3rd"> <div id="report_table_cont">TABLE OF CONTENTS</div> <div id="table_filing"> <a href="#a_001" class="proxy-head-link link-button">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS</a><a href="#a_002" class="proxy-head-link link-button">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a><a href="#a_003" class="proxy-head-link link-button">EXECUTIVE COMPENSATION</a><a href="#a_004" class="proxy-head-link link-button">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a><a href="#a_005" class="proxy-head-link link-button">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a><a href="#a_006" class="proxy-head-link link-button">PROPOSAL NUMBER ONEELECTION OF DIRECTORS</a><a href="#a_007" class="proxy-head-link link-button">PROPOSAL NUMBER TWORATIFICATION OF THE APPOINTMENT OF INDEPENDENT AUDITOR</a><a href="#a_008" class="proxy-head-link link-button">OTHER MATTERS</a> </div> </section> </div> </div> <style> .ended { font-size: 8pt; display: block; } #financeModal { padding: 0 !important; } .reload { font-family: Lucida Sans Unicode; cursor: pointer; } .modal-blur { -webkit-filter: blur(5px); -moz-filter: blur(5px); -o-filter: blur(5px); -ms-filter: blur(5px); filter: blur(5px); } #financeModal .modal-dialog { width: 80%; max-width: none; margin: 0; left: 10%; top: 5%; } #financeModal .modal-content { border: 0; border-radius: 0; } #financeModal .modal-body { overflow-y: auto; } .date { font-size: 9pt; } .active-finance { background-color: #2196f3 !important; color : ffffff !important; } .active-fin-type { background-color: #2196f3 !important; color : ffffff !important; } .finance_type:hover, .finance_type:active, .finance_type:focus { background-color: #ffffff; text-decoration: none; } .finance:hover, .finance:active, .finance:focus { background-color: #ffffff; text-decoration: none; } #finance-div table tbody tr td:not(:first-child) { text-align: right; } .blur { box-shadow: 0px 0px 20px 20px rgba(255, 255, 255, 1); text-shadow: 0px 0px 10px rgba(51, 51, 51, 0.9); transform: scale(0.9); opacity: 0.6; } </style> <style> .gemini-response { font-family: Arial, sans-serif; line-height: 1; } .gemini-response h2, .gemini-response h3 { margin-top: 20px; margin-bottom: 10px; } .gemini-response ul { padding-left: 20px; } .gemini-response ul li { margin-bottom: 10px; } .gemini-response p { margin-bottom: 15px; } .modal-lg { max-width: 50%; } </style> <div aria-hidden="true" aria-labelledby="shareholderModalLabel" class="modal fade " id="shareholderModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="shareholderModalTitle"></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <h2 class="fund-header" id='dynamic-header' style="text-decoration:underline"></h2> <p id="p-fund" style="display: none;">No information found </p> <div id="fund_div"> <p class="small-note ">* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.</p> <div class="table-responsive x-overflow-hide"> <table class="fl-table table" id="fund-table"> <thead> <th onclick="sortTable(0)">FUND</th> <th onclick="sortTable(1)">NUMBER OF SHARES</th> <th onclick="sortTable(2)">VALUE ($)</th> <th>PUT OR CALL</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="directorModalLabel" class="modal fade" id="directorModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="dynamicDirector-header">Directors of Inspired Entertainment, Inc. - as per the latest proxy <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-wrapper-director" id="dircter-table-div"> <table class="fl-table table" id="director-table"> <thead> <th class="directorCol">DIRECTORS</th> <th class="directorCol ageCol">AGE</th> <th class="directorCol">BIO</th> <th class="directorCol">OTHER DIRECTOR MEMBERSHIPS</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> <div aria-labelledby="registerModalLabel" class="modal fade " data-backdrop="static" data-keyboard="false" id="registerModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div> <button class="close pr-2 pt-2" type="button"> <a class="text-dark text-decoration-none" href="/INSE/"> <span aria-hidden="true">×</span></a> </button> </div> <div class="text-center pb-3"><a href="/pricing/">Subscribe</a> to view this or get a <a href="/token/">free 24 hour token </a> or take a free test drive with ticker <a href="/snapshot/AAPL">AAPL</a>. View our demo <a href="/demo/">video</a>. </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="executiveModalLabel" class="modal fade" id="executiveModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id='executiveModalLabelTitle'></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <h2 class="fund-header" style="text-decoration:underline"></h2> <div class="table-responsive"> <div class="table-wrapper-execs" id='executive-button'> <p>No information found </p> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="customerModalLabel" class="modal fade" id="customerModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="cust-header"> Customers and Suppliers of Inspired Entertainment, Inc. <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="container"> <div class="row"> <div class="col-md-6 col-12"> <div class=" table-responsive x-overflow-hide" id="Customer_table"> <p>No Customers Found </p> </tbody> </table> </div> </div> <div class="col-md-6 col-12"> <div class=" table-responsive x-overflow-hide" id="Supplier_table"> <p>No Suppliers Found</p> </tbody> </table> </div> </div> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="bondModalLabel" class="modal fade " id="bondModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="bondModalTitle">Bonds of Inspired Entertainment, Inc.</h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-responsive " id="bond_table"> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="bondpricegraphModalLabel" class="modal fade " id="bondpricegraphModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document" style=" height: 100%;"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="bondpricegraphModalTitle">Price Graph </h5> <button aria-label="Close" class="close" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body" id="price_graph"> <img id="bond_graph" src=""> </div> <div class="row mt-5"> <div class="col-1 mt-2 pr-0"> <h6 style="position: relative;float: right;"><em class="dot red"></em> </h6> </div> <div class="col-11 pl-0"> <p class="text-muted">Price</p> </div> <div class="col-1 mt-2 pr-0"> <h6 style="position: relative;float: right;"><em class="dot"></em> </h6> </div> <div class="col-11 pl-0"> <p class="text-muted">Yield</p> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="InsiderOwnershipModalLabel" class="modal fade " id="InsiderOwnershipModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="insider_ownershipModalTitle">Insider Ownership of Inspired Entertainment, Inc. company <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-wrapper-director" id="insider_ownership_table-div"> <table class="fl-table table" id="insider_ownership_table"> <thead> <th class="insideOwnershipCol">Owner</th> <th class="insideOwnershipCol">Position</th> <th class="insideOwnershipCol">Direct Shares</th> <th class="insideOwnershipCol">Indirect Shares</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> <div class="modal fade" id="aiInsights" tabindex="-1" role="dialog" aria-labelledby="aiInsightsLabel" aria-hidden="true"> <div class="modal-dialog modal-lg" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="aiInsightsLabel">AI Insights</h5> <button type="button" class="close" data-dismiss="modal" aria-label="Close"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div id="geminiResponseContainer" class="gemini-response"> <!-- Response content will be loaded here --> </div> </div> <div class="modal-footer"> <button type="button" class="btn btn-secondary" data-dismiss="modal">Close</button> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="financeModalLabel" class="modal fade " id="financeModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <div> <span> <h5 class="modal-title" id="financeModalTitle">Summary Financials of Inspired Entertainment, Inc. <sup><small>Beta</small></sup></h5> </span> <span style="font-size:80%"> <small>(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)</small> </span> </div> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <input id="ftitle" type="hidden" value=""> <input id="displayed_finance" type="hidden" value="balance"> <input id="displayed_ftype" type="hidden" value="10-Q"> <input id="company_name_hidden" type="hidden" value="Inspired Entertainment, Inc."> <div class="modal-body"> <div class="row"> <div class="col-10"> <div aria-label="Basic example" class="btn-group" role="group"> <button class="btn model_button border border-primary finance p-1 active-finance" id="balance" type="button">Balance Sheet </button> <button class="btn model_button finance p-1" id="income" type="button"> Income Statement </button> <button class="btn model_button finance p-1" id="cash_flow" type="button">Cash Flow </button> </div> </div> <div class="col-2 pull-right"> <div aria-label="Basic example" class="btn-group" role="group" style="float: right;"> <button class="btn model_button finance_type p-1 active-fin-type" id="10-Q" type="button">Quarterly </button> <button class="btn model_button finance_type p-1" id="10-K" type="button">Annual </button> </div> </div> </div> <div class="table-responsive pt-2" id="finance-div"> No information found </div> </div> </div> </div> </div> </div> <script> </script> <script src="/static/js/threeButtonScroll.js?v=9"></script> <script src="/static/js/scroll_js.js?v=7"></script> <script> var ticker = "INSE"; $(document).ready(function() { $('#aiInsights').on('show.bs.modal', function (event) { var companyName = "Inspired Entertainment, Inc."; var csrftoken = $('input[name="csrfmiddlewaretoken"]').val(); // Show loading spinner $('#geminiResponseContainer').html('<div class="text-center"><span class="spinner-border text-primary" role="status"><span class="sr-only">Loading...</span></span></div>'); // Logging the data sent in the AJAX request console.log('Preparing AJAX request with data:', { company_Name: companyName, csrfmiddlewaretoken: csrftoken }); $.ajax({ url: '/api/get_gemini_response/', type: 'POST', data: { 'company_Name': companyName, 'company_Ticker': ticker, 'csrfmiddlewaretoken': csrftoken }, success: function(data) { console.log('AJAX request successful. Data received:', data); if (data.error) { $('#geminiResponseContainer').html(`<div class='alert alert-danger'>Error: ${data.error}</div>`); } else { $('#geminiResponseContainer').html(formatResponse(data.response)); } }, error: function(xhr, status, error) { console.error("AJAX Error:", error); console.error("Detailed response:", xhr.responseText); $('#geminiResponseContainer').html(`<div class='alert alert-danger'>AJAX Error: ${error}</div>`); } }); }); }); function formatResponse(response) { let formattedResponse = response.replace(/\*\*(.*?)\*\*/g, '<strong>$1</strong>'); // Convert **text** to <strong>text</strong> formattedResponse = formattedResponse.replace(/\* (.*?)(\n|$)/g, '<li>$1</li>'); // Convert * text to <li>text</li> formattedResponse = formattedResponse.replace(/<\/li><li>/g, '</li><li>').replace(/<li>/g, '<ul><li>').replace(/<\/li>/g, '</li></ul>'); // Wrap <li> in <ul> formattedResponse = formattedResponse.replace(/## (.*?)(\n|$)/g, '<h2>$1</h2>'); // Convert ## text to <h2>text</h2> formattedResponse = formattedResponse.replace(/### (.*?)(\n|$)/g, '<h3>$1</h3>'); // Convert ### text to <h3>text</h3> formattedResponse = formattedResponse.replace(/\n/g, '<br>'); // Convert newlines to <br> return `<div>${formattedResponse}</div>`; } </script> <script src="/static/js/filing.js?v=1"></script> <script> $("#second").contents().find("body").css({'padding': '1px 4px', 'overflow-x': 'hidden'}) var fid = '1615063', printerLink = "/printer/" + "99710" + "/" + "True" + '/' //Append the print button to TOC function addPrintButton(items, type) { items.forEach((itm) => { itm.innerHTML = itm.innerHTML + '<span class="print">print</span>' itm.addEventListener('mouseover', function () { this.querySelector('span.print').style.display = 'inline-block' }) itm.addEventListener('mouseout', function () { this.querySelector('span.print').style.display = 'none' }) }) $('.' + type + '-link span.print').on('click', function (e) { let part = this.parentElement.hash.replace('#', '') openPrintPortion(part) }) } document.addEventListener('DOMContentLoaded', function () { I_frame = document.querySelector('#second') if (window.innerWidth > '700') { // I_frame.setAttribute('style','border:none;position:absolute;left:0vw;min-width:100%;max-width:100%;top:0vh;height:100%;min-height:100%;') } else { // I_frame.setAttribute('style','border:none;position:absolute;left:0vw;min-width:100vw;max-width:100vw!important;top:0vh;height:100%;min-height:100%;') } let partsInTOC = document.querySelectorAll('.part-link') let itemsInToc = document.querySelectorAll('.item-link') let notesInTOC = document.querySelectorAll('.note-link') addPrintButton(partsInTOC, 'part'); addPrintButton(itemsInToc, 'item'); addPrintButton(notesInTOC, 'note'); /* Toogle between the sections*/ let fillinglist = document.querySelectorAll('.firstsec')[0] let doc_preview = document.querySelectorAll('.document-view-section')[0] let toc = document.querySelectorAll('.toc')[0] let mobile_view = document.querySelectorAll('.mobile_view')[0] /* buttons for toggling */ let showfilings_btn = document.querySelectorAll('.show_filings_btn')[0] let showdoc_btn = document.querySelectorAll('.show_doc_btn')[0] let showtoc_btn = document.querySelectorAll('.show_toc_btn')[0] showfilings_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'block' doc_preview.style.display = 'none' toc.style.display = 'none' mobile_view.style.display = 'block' shortcutsmobile.style.display = 'none' }) showdoc_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'none' doc_preview.style.display = 'block' toc.style.display = 'none' mobile_view.style.display = 'none' shortcutsmobile.style.display = 'block' }) showtoc_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'none' doc_preview.style.display = 'none' toc.style.display = 'block' mobile_view.style.display = 'none' shortcutsmobile.style.display = 'none' }) $(".section document-view-section div").eq(1).after('<div id="doc-head"></div>') }) //track which filing has been clicked on let filingslinks = document.querySelectorAll('.filedate') /* let filingvalue = window.location.href.split('&'); console.log(filingvalue,'filingvaluefilingvalue') if (filingvalue.length===1){ let row =document.querySelector('#filings-section-list').querySelector('tbody').querySelectorAll('tr')[0] row.style.backgroundColor='#d8ecf3'; } else { filingvalue = window.location.href.split('&')[1].split('=')[1]; console.log(filingvalue,'filingvalue') filingslinks.forEach((filing)=>{ if (filing.outerHTML.search(filingvalue) > -1) { filing.setAttribute('style','background-color:#d8ecf3') } }) }*/ function openPrintPortion(portion) { var a = window.open(printerLink + portion, '_blank'); } </script> <script> function numberWithCommasNoDecimal(x) { // If null or undefined, just return dash if (x === null || x === undefined) return '-'; // Convert to float let val = parseFloat(String(x).replace(/,/g, '').trim()); if (isNaN(val)) return '-'; // Track negativity const negative = val < 0; // Work with absolute value for splitting val = Math.abs(val); // Now split at the decimal let [intPart, decimalPart] = val.toString().split('.'); // Insert commas in integer portion only intPart = intPart.replace(/\B(?=(\d{3})+(?!\d))/g, ','); // Reattach sign and decimal let result = negative ? '-' + intPart : intPart; if (decimalPart !== undefined) { result += '.' + decimalPart; } return result; } function fetch_bond_price_graph(bond_symbol) { $("#bond_graph").attr("src","/image/price_graph/"+bond_symbol+".png"); } function clear_div(element) { $('#' + element).html(''); } $(document).ready(function () { var ticker = "INSE"; /***************************************************** * 1) OLD FUNCTION: create_table_new2 (flat structure) *****************************************************/ function create_table_new2( finance_data_section, finance_data_value, finance_data_label, ended_lst, f_data, dates, finance_title ) { if (!f_data || f_data.length === 0) { $('#finance-div').html('<div class="alert alert-info">No financial data available.</div>'); return; } // A quick helper to strip commas and parse float function parseValue(val) { if (val === null || val === undefined) return null; // Already a number if (typeof val === 'number') return val; // If it's a string, remove commas, extra spaces, etc. if (typeof val === 'string') { let cleaned = val.replace(/,/g, '').trim(); let parsed = parseFloat(cleaned); return isNaN(parsed) ? null : parsed; } return null; } var table = ` <div class="text-center"><strong>${finance_title}</strong></div> <table class="fl-table table table-hover" id="finance-table"> <thead> <tr> <th>Field</th>`; // Add headers for each date (same order as ended_lst) ended_lst.forEach(function(date) { table += `<th>${date}</th>`; }); table += `</tr></thead><tbody>`; // Track the last section and sub-section for grouping var lastSection = null; var lastSubSection = null; // f_data = [section, sub_section, label, [values per date]] f_data.forEach(function(item) { var section = item[0]; var sub_section = item[1]; var label = item[2]; var values = item[3]; // If we've hit a new section, print a row if (section && section !== lastSection) { table += ` <tr style="background-color: #000; color: #fff; text-transform: uppercase;"> <td colspan="${ended_lst.length + 1}"> <strong>${section}</strong> </td> </tr>`; lastSection = section; lastSubSection = null; } // If we've hit a new sub-section if (sub_section && sub_section !== lastSubSection) { table += ` <tr style="background-color: #f0f0f0;"> <td colspan="${ended_lst.length + 1}"> <strong>${sub_section}</strong> </td> </tr>`; lastSubSection = sub_section; } // Now the actual row for this label table += `<tr> <td style="padding-left: 20px;">${label}</td>`; // For each value in this row’s array (aligned with ended_lst) values.forEach(function(value) { // Convert to a real float if possible let numericVal = parseValue(value); if (numericVal === null) { // Not a valid float => dash table += `<td>-</td>`; } else { // Format as thousands with commas (keeping negatives and decimals) let formatted = numberWithCommasNoDecimal(numericVal); table += `<td>${formatted}</td>`; } }); table += `</tr>`; }); table += `</tbody></table>`; $('#finance-div').html(table); } /******************************************************* * 2) NEW FUNCTION: createNestedTable (hierarchical) *******************************************************/ function createNestedTable(nested_sections, ended_lst, finance_title) { // 1) Declare "table" in this scope let table = ` <div class="text-center"><strong>${finance_title}</strong></div> <table class="fl-table table table-hover" id="finance-table"> <thead> <tr> <th>Field</th>`; ended_lst.forEach(function(date) { table += `<th>${date}</th>`; }); table += `</tr></thead><tbody>`; // 2) Define processNode *inside* so it can reference "table" function processNode(node, indentLevel) { const leftPadding = indentLevel * 20; table += `<tr> <td style="padding-left:${leftPadding}px; font-weight:${indentLevel === 0 ? 'bold' : 'normal'};"> ${node.label || node.sectionName} </td>`; node.valueByPeriod.forEach(function(val) { if (val === null || val === undefined) { val = '-'; } else { // Attempt to parse even if it's a string if (typeof val === 'string') { let cleaned = val.replace(/,/g, '').trim(); let parsed = parseFloat(cleaned); if (!isNaN(parsed)) { val = numberWithCommasNoDecimal(parsed); } else { val = '-'; } } else if (typeof val === 'number') { val = numberWithCommasNoDecimal(val); } } table += `<td>${val}</td>`; }); table += `</tr>`; // Recurse if (node.children && node.children.length > 0) { node.children.forEach(child => processNode(child, indentLevel + 1)); } } // 3) Loop through top-level nodes nested_sections.forEach(node => { processNode(node, 0); }); table += `</tbody></table>`; $('#finance-div').html(table); } /************************************************ * 3) Show the modal -> call get_ajax_data ************************************************/ $('#financeModal').on('shown.bs.modal', function (e) { get_ajax_data(); }); /************************************************ * 4) get_ajax_data: calls Django endpoint ************************************************/ function get_ajax_data() { console.log($('#company_name_hidden').val()); var company_name = $('#company_name_hidden').val().replace('/', ' ').replace('\\', ' '); console.log(company_name); var cik = "1615063"; // e.g. '123456' var finance_type = $('#displayed_finance').val(); // e.g. 'balance', 'income', 'cash_flow' var data_type = $('#displayed_ftype').val(); // e.g. '10-K', '10-Q' var url = `/get/finance/data/${cik}/${finance_type}/${data_type}/${encodeURIComponent(ticker)}/`; $.ajax({ url: url, method: 'GET', success: function (resp) { $('#finance-div').html(''); if (resp.error) { $('#finance-div').html(`<div class="alert alert-danger">${resp.error}</div>`); } else { console.log(resp); // If server returns nested_sections, show them if (resp.nested_sections && resp.nested_sections.length > 0) { createNestedTable(resp.nested_sections, resp.date, resp.finance_title); } else { // Otherwise, fallback to the old flat approach create_table_new2( resp.finance_data_section, resp.finance_data_value, resp.finance_data_label, resp.ended_lst, resp.f_data, resp.date, resp.finance_title ); } } }, error: function (xhr, status, error) { $('#finance-div').html(`<div class="alert alert-danger">An error occurred: ${error}</div>`); console.error(error); } }); } /************************************************ * 5) On-click handlers for toggling (unchanged) ************************************************/ $(document).on('click', '.finance', function () { $('.finance').removeClass('active-finance'); $(this).addClass('active-finance'); // the button's ID (like "balance" or "income") is stored: $('#displayed_finance').val($(this).attr('id')); get_ajax_data(); // calls the /get/finance/data endpoint }); $(document).on('click', '.finance_type', function () { $('.finance_type').removeClass('active-fin-type'); $(this).addClass('active-fin-type'); // the button's ID ("10-Q" or "10-K") is stored: $('#displayed_ftype').val($(this).attr('id')); get_ajax_data(); }); $("#registerModal").on('shown', function () { console.log(7899809) alert("I want this to appear after the modal has opened!"); }); /* close popover */ $('body').on('click', function (e) { $('[data-toggle="popover"]').each(function () { //the 'is' for buttons that trigger popups //the 'has' for icons within a button that triggers a popup if (!$(this).is(e.target) && $(this).has(e.target).length === 0 && $('.popover').has(e.target).length === 0) { $(this).popover('hide'); } }); }); $('[data-toggle="tooltip"]').tooltip(); $('.exhibit-link').each(function () { href = $(this).attr('href') if (href.search('/www.sec.gov/Archives/edgar/data/') == -1) $(this).attr('href', "https://www.sec.gov/Archives/edgar/data/1615063/000164117225006261/" + href) }); $('.info-btn-circle').on('click', function (e) { $('.info-btn-circle').not(this).popover('hide'); }); if ($('#fixed-content-filing').length > 0) { fetch("/fetch_fixed_content_filing", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": "INSE", "current_filing_name": "Inspired Entertainment, Inc.", "current_filing_filingtype": "DEF 14A", "current_filing_filingdate": "April 25, 2025" }) }) .then(response => response.json()) .then(function (data) { bonds = data.data.bonds directors = data.data.director executives = data.data.executive funds = data.data.funds insider_ownership = data.data.insider_ownership bond_html = '' director_html = '' funds_html = '' executive_html = '' insider_ownership_html = '' if (bonds.length > 0) { bond_html += '<table class="fl-table table" id="bond-table"> <thead> <tr> <th rowspan="2">ISSUER NAME</th> <th rowspan="2">SYMBOL</th> <th rowspan="2">CALLABLE</th> <th rowspan="2">SUB-PRODUCT TYPE</th> <th rowspan="2"> COUPON</th> <th rowspan="2">MATURITY</th> <th class="text-center" colspan="2">RATINGS</th> <th class="text-center" colspan="2">LAST SALE</th><th rowspan="2">GRAPH</th> </tr> <tr> <th>MOODY\'S® </th> <th>S&P</th > <th> PRICE </th> <th>YIELD</th> </tr> </thead> <tbody class = "tbody" > ' for (let i = 0; i < bonds.length; i++) { bond_html += '<tr> <td>' + bonds[i].issuer_name + '</td> <td> '+ bonds[i].symbol + ' </td> <td>' + bonds[i].callable + '</td> <td>' + bonds[i].sub_product_type + '</td> <td>' + bonds[i].coupon + '</td> <td>' + bonds[i].matuarity + '</td> <td>' + bonds[i].moody_rating + '</td> <td>' + bonds[i].s_and_p_rating + '</td> <td>' + bonds[i].last_sale_price + '</td> <td>' + bonds[i].last_sale_yield + '</td> <td> <div class="row justify-content-center"> <button class="btn col" style="font-size: inherit; margin-top: 0px; padding-top: 0px;" data-target="#bondpricegraphModal" onclick="fetch_bond_price_graph(\''+bonds[i].symbol+'\')" data-toggle="modal">Price Graph</button><div></td> </tr>' } bond_html += '</tbody> </table>' } else { bond_html = 'No information found' } $("#bond_table").empty(); $('#bond_table').append(bond_html); if (executives.length > 0) { executive_html = executives } else { executive_html = 'No information found' } $("#executive-button").empty(); $('#executive-button').append(executive_html); document.getElementById("dynamicDirector-header").innerHTML = "Directors of Inspired Entertainment, Inc. - as per the latest proxy " + '<sup><small>Beta</small></sup>'; if (directors.length == 0) { $('#director-table').hide(); $('#dircter-table-div').html('<p>No information found</p>') } else { $('#director-table').show(); for (var i = 0; i < directors.length; i++) { tr = ' <tr >' tr += '<td ><center>' + directors[i][0] + '</center></td>' if (directors[i][1] == null) tr += '<td class=" ageCol" ><center></center></td>' else tr += '<td class=" ageCol" ><center>' + directors[i][1] + '</center></td>' tr += '<td id = "bioCol" ><p>' + directors[i][2] + '</p></td>' other = '' for (k = 0; k < directors[i][3].length; k++) { if (k == directors[i][3].length - 1) { other = other + directors[i][3][k] } else { other = other + directors[i][3][k] + ', ' } } tr += ' <td ><center>' + other + '</center></td>' tr += '</tr>' $('#director-table tbody').append(tr) } } if (funds.length != 0) { date = new Date(data.data.fund_report_date) day = date.getDate(); month = date.toLocaleString('default', { month: 'short' }); year = date.getFullYear(); $("#shareholderModalTitle").text("Top 100 Shareholders of Inspired Entertainment, Inc. as of " + month + ' ' + day + ', ' + year) } else { $("#shareholderModalTitle").text("Top 100 Shareholders of Inspired Entertainment, Inc.") } //$('#cust-header').text( "Customers and Suppliers of Inspired Entertainment, Inc.") for (var i = 0; i < funds.length; i++) { tr = '<tr id="tr_doc">' tr += '<td class="success fund text-uppercase">' + funds[i].fund + '<button type="button" id="' + i + '" class="btn btn-secondary btn-small info-btn-circle" data-container="body" data-title="×" data-toggle="popover" data-placement="top" data-html="true" >i</button></td>' tr += '<td class = "fund-shares" >' + numberWithCommasNoDecimal(funds[i].share_prn_amount) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(funds[i].value) + '</td>' tr += '<td class="success"><center>' + funds[i].put_call + '</center></td>' tr += '</tr>' $('#fund-table tbody').append(tr) } $('[data-toggle="popover"]').popover({sanitize:false, content: function() { var i = $(this).attr('id') text_tooltip = '<div class="container"><div class="row">'+ '<div class="col-4 p-0 font-weight-bold " >Filed By: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].filed_by_name+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '<div class="col-4 p-0 font-weight-bold" >Address: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].address+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '<div class="col-4 p-0 font-weight-bold" >Phone: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].phone+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '</div></div>' return text_tooltip; //return $('#po' + id).html(); } }); if (insider_ownership.length != 0) { for (var i = 0; i < insider_ownership.length; i++) { tr = '<tr id="tr_doc">' tr += '<td class="success fund text-uppercase">' + insider_ownership[i].owner + '</td>' tr += '<td class = "fund-shares" >' + numberWithCommasNoDecimal(insider_ownership[i].position) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(insider_ownership[i].current_direct_shares) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(insider_ownership[i].current_indirect_shares) + '</td>' tr += '</tr>' $('#insider_ownership_table tbody').append(tr) } } else { $('#insider_ownership_table tbody').append('No Data Found') } $("#executiveModalLabelTitle").text("Executives of Inspired Entertainment, Inc. - as per the latest proxy") $('#executive-button table').addClass('table') $('#executive-button table tr:first-child').css('background-color', '#4FC3A1') $('#executive-button table tr td').css('border-right', 'none') $('#executive-button table').addClass('fl-table') $('#executive-button table').attr('border', '0') color = '#4FC3A1'; no = 0; $('#executive-button table tr:first-child td').each(function () { text = $(this).text(); text = text.replace(/\u200B/g, ''); text = text.replace(/[\u200B-\u200D\uFEFF]/g, ''); if (text.trim() == '') { $(this).css('background-color', color) if (no == 0) color = '#324960' } else { if (color == '#4FC3A1') color = '#324960' else color = '#4FC3A1' $(this).css('background-color', color) } no++; }) const table = document.querySelector('#executive-button table'); dates = data.data.yearly_years; ended_lst = data.data.ended_lst; finance_data_section = data.data.finance_data_section; finance_data_value = data.data.finance_data_value; finance_data_label = data.data.finance_data_label; f_data = data.data.f_data; }) } }) </script> </div> </div> </div> </body> <script crossorigin="anonymous" defer integrity="sha384-9/reFTGAW83EW2RDu2S0VKaIzap3H66lZH81PoYlFhbGU+6BZp6G7niu735Sk7lN" src="/static/bootstrap/js/popper.min.js"></script> <script defer src="/static/bootstrap/js/bootstrap.min.js"></script> <script defer src="/static/bootstrap/js/custom.min.js"></script> <script> var today_date = new Date(); today_date.setHours(0); today_date.setMinutes(0); today_date.setSeconds(0); $(document).ready(function() { $('#load-div-graph').show() finance_table_div = $('#finance_table_div') if (finance_table_div.length > 0) { fetch_live_stock_data(initial_call = 'true') setInterval(function() { fetch_live_stock_data() }, 30000) } serverStartTime = new Date("") moment_current_time = moment().tz("America/New_York"); moment_server_time = moment(serverStartTime).tz("America/New_York") var server_difference = (moment_current_time.diff(moment_server_time) / 1000).toFixed(2); var endTime = new Date(); var difference = ((endTime - startTime) / 1000).toFixed(2); //var serverdiff = ((endTime - serverStartTime)/1000).toFixed(2); $('#load_time').text(server_difference + ' s/' + difference + ' s') //MOBILE ONE AND MOBILE THREE var menu = "close"; $(".mobile-one .menu-toggle, .mobile-three .menu-toggle").click(function() { if (menu === "close") { $(this).parent().next(".mobile-nav").css("transform", "translate(0, 0)"); menu = "open"; } else { $(this).parent().next(".mobile-nav").css("transform", "translate(-100%, 0)"); menu = "close"; } }); }) function openNav() { document.getElementById("mySidebar").style.width = "250px"; // document.getElementById("main").style.marginLeft = "250px"; } function closeNav() { document.getElementById("mySidebar").style.width = "0"; // document.getElementById("main").style.marginLeft= "0"; } function change_selected_view(element) { site_view = element.value; if (document.getElementById('site_view').length == 3) { if (site_view === 'filing') { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/' + href.slice(-1) window.location.href = href } else { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/snapshot/' + href.slice(-1) window.location.href = href } } else if (site_view === 'filing') { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/' + href.slice(-1)[0].split('#')[0] window.location.href = href } else { href = window.location.href href = href.split('/') if (href.slice(-1) !== '') { ticker = href.slice(-2, -1) if (ticker[0].length == 1 && /^[1-9]+$/.test(ticker)) { ticker = href.slice(-1) } else if (!/^[a-zA-Z]+$/.test(ticker)) { ticker = href.slice(-3, -2) } } else { ticker = href.slice(-1) } href = href.slice(0, 3).join('/') + '/snapshot/' + ticker window.location.href = href } } function load_document(filedata) { // read text from URL location var request = new XMLHttpRequest(); request.open('GET', filedata.path, true); request.send(null); $('#second #load-div').show(); request.onreadystatechange = function() { if (request.readyState === 4 && request.status === 200) { var type = request.getResponseHeader('Content-Type'); if (type.indexOf("text") !== 1) { $('#load-div').hide(); $("#second").empty(); second = document.getElementById('second') second.insertAdjacentHTML('beforeend', request.responseText) second.scrollTop = 00; $("#filing-title").empty(); $('#filing-title').append(filedata.file_title); return true } } } } function fetch_history_graph_data(element) { ticker = window.location.href.split('/').slice(-1)[0] graph = localStorage.getItem('graph_' + ticker + today_date); if (graph) { $('#graph_div')[0].innerHTML = ''; $('#graph_div').append(graph); } else { localStorage.clear(); fetch("/fetch_history_graph_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": ticker, "years": '1y' }) }) .then(response => response.json()) .then(function(data) { $('#load-div-graph').hide() $('#graph_div').append(data.graph); fetch("/fetch_history_graph_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": ticker, "years": '10y' }) }) .then(response => response.json()) .then(function(data) { $('#load-div-graph').hide() $('#finance_table_div').append(data.table); $('#graph_div')[0].innerHTML = ''; $('#graph_div').append(data.graph); localStorage.setItem('graph_' + ticker + today_date, data.graph); }) }) } } function fetch_history_table_data(element) { table = localStorage.getItem('table_' + ticker + today_date); if (table) { $('#finance_table_div').append(table); } else { fetch("/fetch_history_table_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": window.location.href.split('/').slice(-1)[0], }) }) .then(response => response.json()) .then(function(data) { $('#finance_table_div').append(data.table); localStorage.setItem('table_' + ticker + today_date, data.table); }) } } function fetch_live_stock_data(initial_call = '') { let options = { timeZone: 'America/New_York', hour: 'numeric', minute: 'numeric', second: 'numeric', }; let formatter = new Intl.DateTimeFormat([], options); // "09:00:00" < currentTime < "16:00:00" or forced initial_call const currentTime = String(formatter.format(new Date())); if ((currentTime > '09:00:00' && currentTime < '16:00:00') || initial_call) { fetch("/fetch_live_stock_data", { headers: { "X-CSRFToken": document.getElementById("csrf").querySelector("input").value, "Content-type": "application/json" }, method: "POST", body: JSON.stringify({ // e.g. ticker is last part of the URL "ticker": window.location.href.split('/').slice(-1)[0] }) }) .then(response => response.json()) .then(function(data) { // Sanitize/format the incoming data so no double minus signs, etc. const cleanPrice = sanitizePrice(data.price); const cleanChange = sanitizeChange(data.change, data.change_type); // Update DOM $("#stock_price").empty().append(cleanPrice); $("#stock_price_difference").empty().append( `<div class="stock_${data.change_type}">${cleanChange}</div>` ); // Exchange name if (data.exchange) { $('#exchange_name').text(`(${data.exchange})`); } }) .catch(err => console.error("Error fetching stock data:", err)); } } /** * e.g. turns "$236.8500" into "$236.85" */ function sanitizePrice(rawPrice) { // Remove everything except digits, minus, plus, decimal let numeric = parseFloat(rawPrice.replace(/[^\d.-]/g, '')) || 0; return `$${numeric.toFixed(2)}`; } /** * Normalizes the change string. * Example: raw = "- $-5.8500 (-2.4104%)", changeType="loss" => "-5.85 (-2.41%)" * If changeType="gain", we might do "+5.85 (+2.41%)" instead. */ function sanitizeChange(rawChange, changeType) { // Regex tries to capture something like: "- $-5.8500 (-2.4104%)" // Group 1: optional sign before dollar // Group 2: optional sign + digits for the numeric difference // Group 3: optional sign + digits + % for the parenthetical part // // We'll parse them out, strip extra signs, and reapply a single sign // based on "changeType" (e.g. "loss" => "-"). // const re = /^(-?)\s*\$?(-?[\d.]+)\s*\((-?[\d.]+%)\)\s*$/; const match = rawChange.trim().match(re); if (!match) { // If it doesn't match, fallback: just strip out extra non-digit // and reapply sign from changeType return fallbackClean(rawChange, changeType); } // e.g. match[1] = "-" // match[2] = "-5.8500" // match[3] = "-2.4104%" let diffVal = parseFloat(match[2].replace(/[^\d.-]/g, '')) || 0; let pctVal = parseFloat(match[3].replace(/[^\d.-]/g, '')) || 0; // Decide sign from "changeType" const sign = (changeType === "loss") ? "-" : "+"; // Build final difference & percentage const finalDiff = `${sign}${Math.abs(diffVal).toFixed(2)}`; // e.g. "-5.85" const finalPct = `${sign}${Math.abs(pctVal).toFixed(2)}%`; // e.g. "(-2.41%)" return `${finalDiff} (${finalPct})`; } /** * If the data doesn't match our regex, do a simpler approach: * - strip all non-numerics except sign * - parse & reapply sign from changeType */ function fallbackClean(rawStr, changeType) { let numericVal = parseFloat(rawStr.replace(/[^\d.-]/g, '')) || 0; let sign = (changeType === "loss") ? "-" : "+"; return `${sign}${Math.abs(numericVal).toFixed(2)}`; } </script> </html>